Drug |
KEGG |
Substrate |
Inhibitor |
Inducer |
Abametapir (USAN/INN) |
D10687 |
CYP1A2 |
|
|
Abemaciclib (JAN/USAN/INN) |
D10688 |
CYP3A |
|
|
Abiraterone acetate (JAN/USP) |
D09701 |
CYP3A4 |
|
|
Abrocitinib (JAN/USAN) |
D11400 |
CYP2C19, CYP2C9 |
|
|
Acalabrutinib (JAN/USAN/INN) |
D10893 |
CYP3A |
|
|
Acalabrutinib maleate (USAN) |
D11720 |
CYP3A |
|
|
Acalabrutinib maleate hydrate (JAN) |
D12704 |
CYP3A |
|
|
Aceneuramic acid (JAN/USAN) |
D11016 |
NPL |
|
|
Acetone (NF) |
D02311 |
CYP2E1 |
|
|
Acetylcholine chloride (JP18/USP/INN) |
D00999 |
ACHE |
|
|
Acetylsalicylic acid and lansoprazole |
D10527 |
CYP2C19, CYP3A4 |
|
|
Aclidinium bromide (JAN/USAN/INN) |
D08837 |
BCHE |
CYP2D6, CYP3A4, CYP3A5 |
|
Aclidinium bromide and formoterol fumarate |
D11857 |
UGT |
|
|
Adagrasib (USAN/INN) |
D12301 |
CYP3A4 |
|
|
Ajmaline (JP18) |
D00199 |
CYP2D6 |
|
|
Albuterol and budesonide |
D12757 |
SULT1A3 |
|
|
Alectinib (USAN/INN) |
D10542 |
CYP3A4 |
|
|
Alectinib hydrochloride (JAN) |
D10450 |
CYP3A4 |
|
|
Alfuzosin (INN) |
D07124 |
CYP3A4 |
|
|
Alfuzosin hydrochloride (JAN/USAN) |
D01692 |
CYP3A4 |
|
|
Aliskiren (USAN/INN) |
D03208 |
CYP3A4 |
|
|
Aliskiren fumarate (JAN/USAN) |
D06412 |
CYP3A4 |
|
|
Allopurinol (JP18/USP/INN) |
D00224 |
|
CYP1A2 |
|
Allopurinol sodium |
D07564 |
|
CYP1A2 |
|
Almotriptan (USAN) |
D02824 |
MAOA, CYP3A4, CYP2D6; FMO3 |
|
|
Almotriptan malate (USP) |
D02825 |
MAOA, CYP3A4, CYP2D6; FMO3 |
|
|
Alosetron (INN) |
D07129 |
CYP1A2; CYP3A4, CYP2C9 |
|
|
Alosetron hydrochloride (USAN) |
D02829 |
CYP1A2; CYP3A4, CYP2C9 |
|
|
Alprazolam (JP18/USP/INN) |
D00225 |
CYP3A |
|
|
Alprenolol (INN) |
D07156 |
CYP2D6 |
|
|
Alprenolol hydrochloride (JP18/USAN) |
D01182 |
CYP2D6 |
|
|
Amenamevir (JAN/INN) |
D10564 |
CYP3A |
|
CYP3A, CYP2B6 |
Amfetamine (INN) |
D07445 |
CYP2D6 |
|
|
Amifampridine (USAN/INN) |
D10228 |
NAT |
|
|
Amifampridine phosphate (JAN/USAN) |
D10689 |
NAT |
|
|
Aminophylline (USP/INN) |
D00227 |
CYP1A2 |
|
|
Aminophylline dihydrate |
D11630 |
CYP1A2 |
|
|
Aminophylline hydrate (JP18) |
D05429 |
CYP1A2 |
|
|
Amiodarone (USAN/INN) |
D02910 |
CYP3A4 |
|
|
Amiodarone hydrochloride (JP18/USP) |
D00636 |
CYP3A4 |
|
|
Amitriptyline (INN) |
D07448 |
CYP2D6; CYP1A2, CYP3A4, CYP2C19 |
|
|
Amitriptyline hydrochloride (JP18/USP) |
D00809 |
CYP2D6; CYP1A2, CYP3A4, CYP2C19 |
|
|
Amlodipine (USP/INN) |
D07450 |
CYP3A4 |
|
|
Amlodipine benzoate |
D11881 |
CYP3A4 |
|
|
Amlodipine besilate and atorvastatin calcium |
D08488 |
CYP3A4 |
|
|
Amlodipine besylate (USP) |
D00615 |
CYP3A4 |
|
|
Amlodipine maleate (USAN) |
D02914 |
CYP3A4 |
|
|
Amobarbital (JP18/INN) |
D00555 |
|
|
CYP3A |
Amobarbital sodium (JAN/USP) |
D02252 |
|
|
CYP3A |
Amodiaquine (USP/INN) |
D02922 |
CYP2C8 |
|
|
Amodiaquine hydrochloride (USP) |
D02466 |
CYP2C8 |
|
|
Amoxapine (JP18/USP/INN) |
D00228 |
CYP2D6 |
|
|
Amoxicillin hydrate, clarithromycin and lansoprazole |
D08774 |
CYP2C19, CYP3A4 |
CYP3A4 |
|
Amphetamine sulfate (USP) |
D02074 |
CYP2D6 |
|
|
Ampiroxicam (JP18/INN) |
D01397 |
CYP2C9 |
|
|
Amprenavir (JAN/USAN/INN) |
D00894 |
CYP3A4 |
CYP3A |
CYP3A |
Anagrelide (INN/BAN) |
D07455 |
CYP1A1, CYP1A2 |
|
|
Anagrelide hydrochloride (USP) |
D02933 |
CYP1A1, CYP1A2 |
|
|
Anagrelide hydrochloride hydrate (JAN) |
D10255 |
CYP1A1, CYP1A2 |
|
|
Anamorelin hydrochloride (JAN/USAN) |
D08856 |
CYP3A4 |
|
|
Anastrozole (JP18/USP/INN) |
D00960 |
|
CYP1A2, CYP2C9, CYP3A4 |
|
Apalutamide (JAN/INN) |
D11040 |
CYP2C8, CYP3A4 |
|
CYP3A4, CYP2C19; CYP2C9 |
Apixaban (JAN/USAN/INN) |
D03213 |
CYP3A4, CYP3A5 |
|
|
Aprepitant (JAN/USP/INN) |
D02968 |
CYP3A4 |
CYP3A4 |
CYP3A4, CYP2C9 |
Aprindine (USAN/INN) |
D02969 |
CYP2D6 |
|
|
Aprindine hydrochloride (JP18/USAN) |
D01326 |
CYP2D6 |
|
|
Aprocitentan (USAN/INN) |
D11441 |
UGT1A1, UGT2B7 |
|
|
Aranidipine (JAN/INN) |
D01562 |
CYP3A4 |
|
|
Argatroban (USP) |
D00181 |
CYP3A4 |
|
|
Aripiprazole (JAN/USP/INN) |
D01164 |
CYP3A4, CYP2D6 |
|
|
Aripiprazole cavoxil (USAN) |
D10355 |
CYP3A4, CYP2D6 |
|
|
Aripiprazole hydrate (JAN) |
D10516 |
CYP3A4, CYP2D6 |
|
|
Aripiprazole lauroxil (USAN) |
D10364 |
CYP3A4, CYP2D6 |
|
|
Armodafinil (USAN/INN) |
D03215 |
CYP3A4, CYP3A5 |
|
|
Artemether and lumefantrine |
D02484 |
CYP3A |
|
|
Asciminib (USAN/INN) |
D11403 |
CYP3A4, UGT2B7, UGT2B17 |
|
|
Asciminib hydrochloride (JAN/USAN) |
D11404 |
CYP3A4, UGT2B7, UGT2B17 |
|
|
Asenapine (INN) |
D11769 |
CYP1A2 |
CYP2D6 |
|
Asenapine maleate (JAN/USAN) |
D02995 |
CYP1A2 |
CYP2D6 |
|
Aspirin and omeprazole |
D11616 |
CYP2C19; CYP3A4 |
|
|
Astemizole (JAN/USP/INN) |
D00234 |
CYP3A |
|
|
Asunaprevir (JAN/USAN) |
D10093 |
CYP3A |
CYP2D6 |
CYP3A4 |
Atazanavir (INN) |
D07471 |
|
CYP3A4, UGT1A1 |
|
Atazanavir and cobicistat |
D10753 |
CYP3A4 |
CYP3A, CYP2D6; CYP2C8, UGT1A1 |
|
Atazanavir sulfate (JAN/USAN) |
D01276 |
|
CYP3A4, UGT1A1 |
|
Atenolol (JP18/USP/INN) |
D00235 |
CYP2D6 |
|
|
Atogepant (USAN) |
D11313 |
CYP3A4 |
|
|
Atomoxetine (USP/INN) |
D07473 |
CYP2D6 |
|
|
Atomoxetine hydrochloride (JAN/USP) |
D02574 |
CYP2D6 |
|
|
Atorvastatin (INN) |
D07474 |
CYP3A4 |
|
|
Atorvastatin calcium (USP) |
D02258 |
CYP3A4 |
|
|
Atorvastatin calcium anhydorous |
D00887 |
CYP3A4 |
|
|
Atorvastatin calcium propylene glycol solvate |
D11095 |
CYP3A4 |
|
|
Atovaquone and proguanil hydrochloride |
D02472 |
CYP2C19 |
|
|
Avacopan (JAN/USAN/INN) |
D11093 |
CYP3A4 |
|
|
Avanafil (USAN/INN) |
D03217 |
CYP3A4 |
|
|
Avatrombopag (USAN/INN) |
D10306 |
CYP3A4, CYP2C9 |
|
|
Avatrombopag maleate (JAN/USAN) |
D10307 |
CYP3A4, CYP2C9 |
|
|
Axitinib (JAN/USAN) |
D03218 |
CYP3A4, CYP3A5 |
|
|
Azelastine hydrochloride and fluticasone propionate |
D11656 |
CYP3A4 |
|
|
Azelnidipine (JP18/INN) |
D01145 |
CYP3A4 |
|
|
Azilsartan (JAN/USAN/INN) |
D08864 |
CYP2C9 |
|
|
Azilsartan and amlodipine besilate |
D10524 |
CYP3A4 |
|
|
Barnidipine (INN) |
D07494 |
CYP3A4 |
|
|
Barnidipine hydrochloride (JAN) |
D01104 |
CYP3A4 |
|
|
Beclomethasone dipropionate (USP) |
D00689 |
CYP3A4 |
|
|
Beclomethasone dipropionate monohydrate |
D11572 |
CYP3A4 |
|
|
Bedaquiline (USAN/INN) |
D09872 |
CYP3A4 |
|
|
Bedaquiline fumarate (JAN/USAN) |
D09873 |
CYP3A4 |
|
|
Belinostat (USAN/INN) |
D08870 |
UGT1A1; CYP2A6, CYP2C9, CYP3A4 |
|
|
Belzutifan (JAN/USAN/INN) |
D11954 |
UGT2B17, CYP2C19; CYP3A4 |
|
|
Benazepril (INN) |
D07499 |
UGT |
|
|
Benazepril hydrochloride (JAN/USP) |
D00620 |
UGT |
|
|
Benidipine (INN) |
D07509 |
CYP3A4 |
|
|
Benidipine hydrochloride (JP18) |
D02045 |
CYP3A4 |
|
|
Benzbromarone (JP18/USAN/INN) |
D01056 |
CYP2C9 |
CYP2C9 |
|
Benzhydrocodone (USAN/INN) |
D10612 |
CYP2D6, CYP3A4 |
|
|
Benzhydrocodone and acetaminophen |
D11628 |
CYP2D6, CYP3A4 |
|
|
Benzhydrocodone hydrochloride (USAN) |
D10692 |
CYP2D6, CYP3A4 |
|
|
Bepridil (INN) |
D07520 |
CYP2D6, CYP2C9, CYP3A4 |
CYP2D6 |
|
Bepridil hydrochloride (USAN) |
D00631 |
CYP2D6, CYP2C9, CYP3A4 |
CYP2D6 |
|
Berotralstat (USAN/INN) |
D11673 |
|
CYP2D6, CYP3A4 |
|
Berotralstat hydrochloride (JAN/USAN) |
D11674 |
|
CYP2D6, CYP3A4 |
|
Berythromycin (USAN/INN) |
D03098 |
CYP3A |
CYP3A |
|
Betamethasone acetate and betamethasone sodium phosphate |
D04446 |
CYP3A4 |
|
|
Betamethasone and d-chlorpheniramine maleate |
D04447 |
CYP3A4 |
|
|
Bexagliflozin (USAN) |
D10865 |
UGT1A9; CYP3A |
|
|
Bexarotene (JAN/USAN/INN) |
D03106 |
|
|
CYP3A |
Bicalutamide (JP18/USP/INN) |
D00961 |
|
CYP3A4 |
|
Blonanserin (JAN/INN) |
D01176 |
CYP3A4 |
|
|
Boceprevir (INN/USAN) |
D08876 |
|
CYP3A |
|
Bopindolol (INN) |
D07537 |
CYP2D6 |
|
|
Bopindolol malonate (JAN) |
D01794 |
CYP2D6 |
|
|
Bosentan (INN) |
D07538 |
CYP2C9, CYP3A4 |
|
CYP2C9, CYP3A4 |
Bosentan (USAN) |
D01227 |
CYP2C9, CYP3A4 |
|
CYP2C9, CYP3A4 |
Bosutinib (USAN) |
D03252 |
CYP3A4 |
|
|
Bosutinib hydrate (JAN) |
D09728 |
CYP3A4 |
|
|
Brexpiprazole (JAN/USAN/INN) |
D10309 |
CYP3A4, CYP2D6 |
|
|
Brigatinib (JAN/USAN) |
D10866 |
CYP3A4 |
|
|
Brincidofovir (USAN) |
D10547 |
CYP4F2 |
|
|
Brinzolamide and timolol maleate |
D10512 |
CYP3A4, CYP2D6; CYP2A6, CYP2B6, CYP2C8, CYP2C9 |
|
|
Brivaracetam (JAN/USAN/INN) |
D08879 |
CYP2C19 |
|
|
Bromocriptine (USAN/INN) |
D03165 |
CYP3A4 |
CYP3A4 |
|
Bromocriptine mesylate (USP) |
D00780 |
CYP3A4 |
CYP3A4 |
|
Bromperidol (JAN/USAN/INN) |
D01101 |
CYP3A4 |
|
|
Bromperidol decanoate (USAN) |
D02626 |
CYP3A4 |
|
|
Brotizolam (JP18/USAN/INN) |
D01744 |
CYP3A4 |
|
|
Budesonide (JP18/USP/INN) |
D00246 |
CYP3A4 |
|
|
Budesonide and formoterol fumarate dihydrate |
D09595 |
CYP3A4, UGT |
|
|
Bunitrolol hydrochloride (JAN) |
D01444 |
CYP2D6 |
|
|
Bupivacaine (USAN/INN) |
D07552 |
CYP3A4 |
|
|
Bupivacaine hydrochloride (USP) |
D01450 |
CYP3A4 |
|
|
Buprenorphine (JAN/INN) |
D07132 |
CYP3A4 |
|
|
Buprenorphine hydrochloride (JP18/USP) |
D00836 |
CYP3A4 |
|
|
Butalbital, acetaminophen, caffeine and codeine phosphate |
D11851 |
CYP1A2, UGT2B7, UGT2B4; CYP3A4, CYP2D6 |
|
|
Butalbital, aspirin, caffeine and codeine |
D11860 |
UGT2B7, UGT2B4, CYP3A4, CYP2D6 |
|
|
Cabazitaxel (USAN/INN) |
D09755 |
CYP3A |
|
|
Cabazitaxel acetonate (JAN) |
D10452 |
CYP3A |
|
|
Cabergoline (JP18/USP/INN) |
D00987 |
CYP3A4 |
|
|
Cabotegravir (JAN/USAN/INN) |
D10548 |
UGT1A1; UGT1A9 |
|
|
Cabotegravir and rilpivirine |
D11966 |
UGT1A1, CYP3A; UGT1A9 |
|
|
Cabotegravir sodium (JAN/USAN) |
D10549 |
UGT1A1; UGT1A9 |
|
|
Caffeine (USP) |
D00528 |
CYP1A2; CYP3A4, CYP2E1 |
|
|
Caffeine citrate (USP) |
D07603 |
CYP1A2; CYP3A4, CYP2E1 |
|
|
Caffeine hydrate (JP18) |
D01453 |
CYP1A2; CYP3A4, CYP2E1 |
|
|
Calcifediol (USP/INN) |
D00122 |
CYP27B1, CYP24A1 |
|
|
Canagliflozin (USAN/INN) |
D09592 |
UGT1A9, UGT2B4 |
|
|
Candesartan (USAN/INN) |
D00522 |
CYP2C9 |
|
|
Candesartan cilexetil (JP18/USP) |
D00626 |
CES, CYP2C9 |
|
|
Candesartan cilexetil and anmlodipine besylate (JP18) |
D07569 |
CYP3A4 |
|
|
Cannabidiol (JAN/USAN/INN) |
D10915 |
CYP3A4, CYP2C19, UGT1A7, UGT1A9, UGT2B7 |
|
|
Capecitabine (JAN/USP/INN) |
D01223 |
CYP2C9 |
|
|
Capivasertib (JAN/USAN) |
D11371 |
CYP3A4, UGT2B7 |
|
|
Capmatinib (USAN/INN) |
D10696 |
CYP3A4, AOX1 |
|
|
Capmatinib hydrochloride (USAN) |
D10891 |
CYP3A4, AOX1 |
|
|
Carbamazepine (JP18/USP/INN) |
D00252 |
CYP3A4 |
|
CYP3A4 |
Carbidopa, levodopa and entacapone |
D10293 |
|
CYP2C9, COMT |
|
Cariprazine (USAN/INN) |
D09997 |
CYP3A4; CYP2D6 |
|
|
Cariprazine hydrochloride (JAN/USAN) |
D09876 |
CYP3A4; CYP2D6 |
|
|
Carisoprodol (JAN/USP/INN) |
D00768 |
CYP2C19 |
|
|
Carisoprodol and aspirin |
D11586 |
CYP2C19 |
|
|
Carisoprodol, aspirin and codeine phosphate |
D11587 |
CYP2C19 |
|
|
Carotegrast methyl (JAN) |
D09799 |
|
CYP3A4 |
|
Carteolol (INN) |
D07624 |
CYP2D6 |
|
|
Carteolol hydrochloride (JP18/USP) |
D00599 |
CYP2D6 |
|
|
Carvedilol (JP18/USP/INN) |
D00255 |
CYP2D6, CYP2C9, CYP3A4, CYP1A2, CYP2E1 |
|
|
Carvedilol phosphate (USAN) |
D03415 |
CYP2D6, CYP2C9, CYP3A4, CYP1A2, CYP2E1 |
|
|
Celecoxib (JP18/USP/INN) |
D00567 |
CYP2C9 |
CYP2D6 |
|
Cenobamate (USAN/INN) |
D11150 |
UGT2B7, CYP2E1, CYP2A6, CYP2B6; UGT2B4, CYP2C19, CYP3A4, CYP3A5 |
|
|
Ceritinib (JAN/USAN/INN) |
D10551 |
CYP3A |
CYP2C9 |
|
Cerivastatin (INN) |
D07661 |
CYP2C8, CYP3A4 |
|
|
Cerivastatin sodium (JAN/USAN) |
D00889 |
CYP2C8, CYP3A4 |
|
|
Cevimeline (INN) |
D07667 |
CYP2D6, CYP3A4 |
|
|
Cevimeline hydrochloride (USAN) |
D00661 |
CYP2D6, CYP3A4 |
|
|
Chloramphenicol (JP18/USP/INN) |
D00104 |
|
CYP2C19 |
|
Chlorpheniramine polistirex and codeine polistirex |
D12313 |
UGT2B7, UGT2B4, CYP3A4, CYP2D6 |
|
|
Chlorpromazine (USP/INN) |
D00270 |
CYP2D6 |
CYP2D6 |
|
Chlorpromazine hibenzate (JAN) |
D03274 |
CYP2D6 |
CYP2D6 |
|
Chlorpromazine hydrochloride (JP18/USP) |
D00789 |
CYP2D6 |
CYP2D6 |
|
Chlorpromazine hydrochloride, promethazine hydrochloride and phenobarbital |
D02615 |
CYP3A, CYP2D6 |
|
|
Chlorpromazine phenolphthalinate (JAN) |
D04034 |
CYP2D6 |
CYP2D6 |
|
Chlorpromazine tannate (JAN) |
D09819 |
CYP2D6 |
CYP2D6 |
|
Choline fenofibrate (USAN/INN) |
D08890 |
UGT |
|
|
Ciclesonide (JAN/USAN/INN) |
D01703 |
CYP3A4 |
|
|
Cifenline (USAN) |
D03492 |
CYP2D6, CYP3A4 |
|
|
Cifenline succinate (USAN) |
D01455 |
CYP2D6, CYP3A4 |
|
|
Cilnidipine (JP18/INN) |
D01173 |
CYP3A4; CYP2C19 |
|
|
Cilostazol (JP18/USP/INN) |
D01896 |
CYP3A4; CYP2D6, CYP2C19 |
|
|
Cimetidine (JP18/USP/INN) |
D00295 |
|
CYP2D6, CYP3A4 |
|
Cimetidine hydrochloride (USP) |
D03503 |
|
CYP2D6, CYP3A4 |
|
Cinacalcet (USAN) |
D03504 |
CYP3A4 |
CYP2D6 |
|
Cinacalcet hydrochloride (JAN/USAN) |
D03505 |
CYP3A4 |
CYP2D6 |
|
Cinnarizine (JAN/USAN/INN) |
D01295 |
CYP2D6 |
|
|
Cinnarizine dihydrochloride |
D07734 |
CYP2D6 |
|
|
Ciprofloxacin (JP18/USP/INN) |
D00186 |
|
CYP1A2 |
|
Ciprofloxacin hydrate (JAN) |
D10822 |
|
CYP1A2 |
|
Ciprofloxacin hydrochloride (USP) |
D02216 |
|
CYP1A2 |
|
Ciprofloxacin lactate |
D07702 |
|
CYP1A2 |
|
Cisapride (JAN) |
D02092 |
CYP3A |
|
|
Cisapride (USP/INN) |
D00274 |
CYP3A |
|
|
Citalopram (USP/INN) |
D07704 |
CYP3A4, CYP2D6 |
CYP2C19 |
|
Citalopram hydrobromide (USP) |
D00822 |
CYP3A4, CYP2D6 |
CYP2C19 |
|
Citalopram hydrochloride |
D07705 |
CYP3A4, CYP2D6 |
CYP2C19 |
|
Clarithromycin (JP18/USP/INN) |
D00276 |
CYP3A4 |
CYP3A4 |
|
Clarithromycin lactobionate |
D07710 |
CYP3A4 |
CYP3A4 |
|
Clemastine (USAN) |
D03535 |
|
CYP2D6 |
|
Clemastine fumarate (JP18/USP) |
D00666 |
|
CYP2D6 |
|
Clobazam (JAN/USAN/INN) |
D01253 |
CYP3A4, CYP2C19 |
|
|
Clomipramine (INN) |
D07727 |
CYP2D6; CYP1A2, CYP3A4, CYP2C19 |
|
|
Clomipramine hydrochloride (JP18/USP) |
D00811 |
CYP2D6; CYP1A2, CYP3A4, CYP2C19 |
|
|
Clopidogrel (USP/INN) |
D07729 |
CYP2C19; CYP3A4, CYP1A2, CYP2B6 |
CYP2C8 |
|
Clopidogrel besilate |
D10824 |
CYP2C19; CYP3A4, CYP1A2, CYP2B6 |
CYP2C8 |
|
Clopidogrel bisulfate (USP) |
D00769 |
CYP2C19; CYP3A4, CYP1A2, CYP2B6 |
CYP2C8 |
|
Clopidogrel hydrochloride |
D10823 |
CYP2C19; CYP3A4, CYP1A2, CYP2B6 |
CYP2C8 |
|
Clopidogrel sulfate and aspirin |
D10513 |
CYP2C19; CYP1A2, CYP2B6, CYP3A4 |
CYP2C8 |
|
Clotrimazole (JP18/USP/INN) |
D00282 |
|
CYP3A4 |
|
Clozapine (JAN/USP/INN) |
D00283 |
CYP1A2, CYP3A4 |
|
|
Co-Trimoxazole (BAN) |
D00285 |
|
CYP2C8, CYP2C9 |
|
Cobicistat (JAN/USAN/INN) |
D09881 |
CYP3A; CYP2D6 |
CYP3A, CYP2D6 |
|
Codeine (USP) |
D00195 |
UGT2B7, UGT2B4; CYP3A4, CYP2D6 |
|
|
Codeine hydrochloride |
D07740 |
UGT2B7, UGT2B4; CYP3A4, CYP2D6 |
|
|
Codeine phosphate (USP) |
D02101 |
UGT2B7, UGT2B4; CYP3A4, CYP2D6 |
|
|
Codeine phosphate and chlorpheniramine maleate |
D12312 |
UGT2B7, UGT2B4; CYP3A4, CYP2D6 |
|
|
Codeine polistirex (USAN) |
D03579 |
UGT2B7, UGT2B4; CYP3A4, CYP2D6 |
|
|
Codeine sulfate (USP) |
D03580 |
UGT2B7, UGT2B4; CYP3A4, CYP2D6 |
|
|
Colchicine (JP18/USP) |
D00570 |
CYP3A4 |
|
|
Colforsin (USAN/INN) |
D03584 |
CYP3A |
|
|
Colforsin daropate hydrochloride (JAN) |
D01697 |
CYP3A |
|
|
Compound oxycodone (JP18) |
D02175 |
CYP3A4; CYP2D6 |
|
|
Conivaptan (INN) |
D07748 |
CYP3A |
CYP3A |
|
Conivaptan hydrochloride (JAN/USAN) |
D01236 |
CYP3A |
CYP3A |
|
Copanlisib (USAN/INN) |
D10867 |
CYP3A; CYP1A1 |
|
|
Copanlisib hydrochloride (USAN) |
D10797 |
CYP3A; CYP1A1 |
|
|
Copanlisib hydrochloride hydrate (JAN) |
D10798 |
CYP3A; CYP1A1 |
|
|
Crizotinib (JAN/USAN/INN) |
D09731 |
CYP3A4, CYP3A5 |
CYP2B6, CYP3A |
|
Cyclophosphamide (INN) |
D07760 |
CYP2B6; CYP2A6, CYP2C8, CYP2C9, CYP3A4 |
|
|
Cyclophosphamide (USP) |
D00287 |
CYP2B6; CYP2A6, CYP2C8, CYP2C9, CYP3A4 |
|
|
Cyclosporine (USP) |
D00184 |
CYP3A4 |
CYP3A4 |
|
Dabrafenib (USAN) |
D10064 |
CYP3A4, CYP2C8 |
|
CYP3A4, CYP2C9 |
Dabrafenib mesylate (USAN) |
D10104 |
CYP3A4, CYP2C8 |
|
CYP3A4, CYP2C9 |
Daclatasvir (USAN) |
D10065 |
CYP3A4 |
CYP3A, UGT1A1 |
|
Daclatasvir dihydrochloride (USAN) |
D10105 |
CYP3A4 |
CYP3A, UGT1A1 |
|
Daclatasvir, asunaprevir and beclabuvir |
D10882 |
CYP3A |
|
CYP3A4 |
Dacomitinib (INN) |
D09883 |
|
CYP2D6 |
|
Dacomitinib (USAN) |
D10514 |
|
CYP2D6 |
|
Dantrolene (USAN/INN) |
D02347 |
CYP1A1, CYP1A2, CYP3A |
|
|
Dantrolene sodium (USP) |
D02274 |
CYP1A1, CYP1A2, CYP3A |
|
|
Dapagliflozin (JAN/USAN/INN) |
D08897 |
UGT1A9 |
|
|
Dapagliflozin propanediol (USAN) |
D09763 |
UGT1A9 |
|
|
Dapsone (USP) |
D00592 |
CYP2E1, CYP3A4 |
|
|
Daridorexant (USAN/INN) |
D11886 |
CYP3A4 |
|
|
Daridorexant hydrochloride (JAN/USAN) |
D11887 |
CYP3A |
|
|
Darifenacin (USAN/INN) |
D03654 |
CYP3A4, CYP2D6 |
|
|
Darifenacin hydrobromide (JAN/USAN) |
D01699 |
CYP3A4, CYP2D6 |
|
|
Darunavir (USAN/INN) |
D03656 |
CYP3A4 |
CYP3A4 |
|
Darunavir ethanolate (JAN) |
D06478 |
CYP3A4 |
CYP3A4 |
|
Darunavir hydrate |
D12637 |
CYP3A4 |
CYP3A4 |
|
Darunavir propylene glycolate |
D12752 |
CYP3A4 |
CYP3A4 |
|
Dasabuvir, ombitasvir, paritaprevir and ritonavir |
D10582 |
CYP3A, CYP2C8 |
CYP3A4, UGT1A1 |
|
Dasatinib (JAN/INN) |
D03658 |
CYP3A4, FMO3, UGT |
|
|
Dasatinib (USAN) |
D06414 |
CYP3A4, FMO3, UGT |
|
|
Dasatinib laurylsulfate (USAN) |
D12609 |
CYP3A4, FMO3, UGT |
|
|
Debrisoquin sulfate (USAN) |
D03664 |
CYP2D6 |
|
|
Deferasirox (JAN/USAN/INN) |
D03669 |
UGT1A1, UGT1A3 |
CYP1A2, CYP2C8 |
CYP3A4 |
Deflazacort (USAN/INN) |
D03671 |
CYP3A4 |
|
|
Delamanid (JAN/USAN) |
D09785 |
CYP3A4, CYP1A1, CYP2D6, CYP2E1 |
|
|
Delavirdine (INN) |
D07782 |
CYP3A |
CYP3A |
|
Delavirdine mesylate (USAN) |
D00895 |
CYP3A |
CYP3A |
|
Desvenlafaxine (INN) |
D07793 |
CYP3A4, UGT |
|
|
Desvenlafaxine succinate (USAN) |
D02570 |
CYP3A4, UGT |
|
|
Desvenlafaxine succinate anhydrous |
D11619 |
UGT; CYP3A4 |
|
|
Deucravacitinib (JAN/USAN) |
D11817 |
CYP1A2; CYP2B6, CYP2D6, CES2, UGT1A9 |
|
|
Dexamethasone (JP18/USP/INN) |
D00292 |
CYP3A4 |
|
CYP3A4 |
Dexamethasone 21-acetate |
D07796 |
CYP3A4 |
|
CYP3A4 |
Dexamethasone 21-tebutate |
D07799 |
CYP3A4 |
|
CYP3A4 |
Dexamethasone 21-valerate |
D07800 |
CYP3A4 |
|
CYP3A4 |
Dexamethasone acefurate (USAN/INN) |
D02591 |
CYP3A4 |
|
CYP3A4 |
Dexamethasone acetate (JAN/USP) |
D02174 |
CYP3A4 |
|
CYP3A4 |
Dexamethasone beloxil (USAN) |
D02592 |
CYP3A4 |
|
CYP3A4 |
Dexamethasone cipecilate (JAN/INN) |
D07073 |
CYP3A4 |
|
CYP3A4 |
Dexamethasone dipropionate (USAN) |
D01632 |
CYP3A4 |
|
CYP3A4 |
Dexamethasone isonicotinate |
D07797 |
CYP3A4 |
|
CYP3A4 |
Dexamethasone metasulfobenzoate sodium (JAN) |
D01510 |
CYP3A4 |
|
CYP3A4 |
Dexamethasone palmitate (JAN) |
D01615 |
CYP3A4 |
|
CYP3A4 |
Dexamethasone phenylpropionate |
D07801 |
CYP3A4 |
|
CYP3A4 |
Dexamethasone phosphate |
D07802 |
CYP3A4 |
|
CYP3A4 |
Dexamethasone sodium hemisulfate |
D07798 |
CYP3A4 |
|
CYP3A4 |
Dexamethasone sodium phosphate (JAN/USP) |
D00975 |
CYP3A4 |
|
CYP3A4 |
Dexamethasone valerate (JAN) |
D01948 |
CYP3A4 |
|
CYP3A4 |
Dexchlorpheniramine (INN) |
D07803 |
CYP2D6, CYP3A |
CYP2D6 |
|
Dexchlorpheniramine maleate (USP) |
D00668 |
CYP2D6, CYP3A |
CYP2D6 |
|
Dexfenfluramine (INN) |
D07805 |
CYP2D6 |
|
|
Dexfenfluramine hydrochloride (USAN) |
D03713 |
CYP2D6 |
|
|
Dexlansoprazole (INN/USAN) |
D08903 |
CYP2C19, CYP3A4 |
CYP2C19 |
|
Dexlansoprazole sesquihydrate |
D12816 |
CYP2C19, CYP3A4 |
CYP2C19 |
|
Dexmedetomidine (USAN/INN) |
D00514 |
CYP2A6; CYP1A2, CYP2E1, CYP2D6, CYP2C19 |
|
|
Dexmedetomidine hydrochloride (JAN/USP) |
D01205 |
CYP2A6; CYP1A2, CYP2E1, CYP2D6, CYP2C19 |
|
|
Dextroamphetamine (USAN) |
D03740 |
CYP2D6 |
|
|
Dextroamphetamine sulfate (USP) |
D02078 |
CYP2D6 |
|
|
Dextromethorphan (USP) |
D03742 |
CYP2D6 |
|
|
Dextromethorphan hydrobromide (USP) |
D00848 |
CYP2D6 |
|
|
Dextromethorphan hydrobromide and bupropion hydrochloride |
D12493 |
CYP2D6 |
|
|
Dextromethorphan hydrobromide and potassium cresolsulfonate |
D04340 |
CYP2D6, CYP3A4 |
|
|
Dextromethorphan polistirex (USAN) |
D03744 |
CYP2D6 |
|
|
Diazepam (JP18/USP/INN) |
D00293 |
CYP2C19, CYP3A4 |
|
|
Diclofenac (USAN/INN) |
D07816 |
CYP2C9 |
|
|
Diclofenac calcium |
D07819 |
CYP2C9 |
|
|
Diclofenac diethylamine |
D07817 |
CYP2C9 |
|
|
Diclofenac epolamine |
D07818 |
CYP2C9 |
|
|
Diclofenac potassium (USP) |
D00903 |
CYP2C9 |
|
|
Diclofenac sodium (JP18/USP) |
D00904 |
CYP2C9 |
|
|
Dienogest (JAN/USAN/INN) |
D03799 |
CYP3A4 |
|
|
Dienogest and estradiol valerate |
D10461 |
CYP3A |
|
|
Digitoxin (JAN/USP/INN) |
D00297 |
CYP3A |
|
|
Dihydrocodeine (INN) |
D07831 |
UGT2B7, UGT2B4; CYP3A4, CYP2D6 |
|
|
Dihydrocodeine bitartrate (USP) |
D03825 |
UGT2B7, UGT2B4; CYP3A4, CYP2D6 |
|
|
Dihydrocodeine phosphate (JP18) |
D01481 |
UGT2B7, UGT2B4; CYP3A4, CYP2D6 |
|
|
Dihydrocodeine phosphate, dl-methylephedrine hydrochloride and Chlorpheniramine maleate |
D04313 |
UGT2B7, UGT2B4; CYP3A4, CYP2D6 |
|
|
Dihydrocodeine phosphate, ephedrine hydrochloride and ammmonium chloride |
D04338 |
UGT2B7, UGT2B4; CYP3A4, CYP2D6 |
|
|
Dihydrocodeine thiocyanate |
D07832 |
UGT2B7, UGT2B4; CYP3A4, CYP2D6 |
|
|
Dihydroergotamine (INN) |
D07837 |
CYP3A4 |
|
|
Dihydroergotamine mesylate (USP) |
D02211 |
CYP3A4 |
|
|
Dihydroergotamine tartrate |
D07838 |
CYP3A4 |
|
|
Dihydroergotoxine |
D07839 |
CYP3A4 |
|
|
Diltiazem (INN) |
D07845 |
CYP3A4 |
|
|
Diltiazem hydrochloride (JP18/USP) |
D00616 |
CYP3A4 |
|
|
Diltiazem malate (USAN) |
D03830 |
CYP3A4 |
|
|
Disopyramide (JP18/USAN/INN) |
D00303 |
CYP3A4 |
|
|
Disopyramide phosphate (JAN/USP) |
D00637 |
CYP3A4 |
|
|
Disulfiram (JP18/USP/INN) |
D00131 |
|
CYP2E1, CYP1A2 |
|
Docetaxel (JAN/INN) |
D07866 |
CYP3A4 |
|
|
Docetaxel (USP) |
D02165 |
CYP3A4 |
|
|
Dolasetron (INN) |
D07867 |
CYP2D6, CYP3A |
|
|
Dolasetron mesylate (USP) |
D00725 |
CYP2D6, CYP3A |
|
|
Dolutegravir (USAN) |
D10066 |
UGT1A1; CYP3A4 |
|
|
Dolutegravir sodium (JAN/USAN) |
D10113 |
UGT1A1; CYP3A4 |
|
|
Dolutegravir sodium and rilpivirine hydrochloride |
D11282 |
CYP3A, UGT1A1 |
|
|
Dolutegravir, abacavir and lamivudine |
D10600 |
UGT1A1; CYP3A4 |
|
|
Domperidone (JP18/USAN/INN) |
D01745 |
CYP3A4 |
|
|
Domperidone maleate |
D07868 |
CYP3A4 |
|
|
Donepezil (JAN/INN) |
D07869 |
CYP3A4; CYP2D6 |
|
|
Donepezil hydrochloride (JP18/USP) |
D00670 |
CYP3A4; CYP2D6 |
|
|
Dopamine (INN) |
D07870 |
MAOB, COMT |
|
|
Dopamine hydrochloride (JP18/USP) |
D00633 |
MAOB, COMT |
|
|
Doravirine (JAN/USAN/INN) |
D10624 |
CYP3A |
|
|
Doravirine, lamivudine and tenofovir disoproxil |
D11396 |
CYP3A |
|
|
Dorzolamide (INN) |
D07871 |
CYP2C9, CYP2C19, CYP3A4 |
|
|
Dorzolamide hydrochloride (JP18/USP) |
D00653 |
CYP2C9, CYP2C19, CYP3A4 |
|
|
Dorzolamide hydrochloride and timolol maleate (JP18) |
D08493 |
CYP2C9, CYP2C19, CYP3A4, CYP2D6 |
|
|
Dosulepin (INN) |
D07872 |
CYP2D6 |
|
|
Dothiepin hydrochloride (USAN) |
D01546 |
CYP2D6 |
|
|
Doxapram (INN) |
D07873 |
CYP3A4, CYP3A5 |
|
|
Doxapram hydrochloride (USP) |
D01872 |
CYP3A4, CYP3A5 |
|
|
Doxepin (INN) |
D07875 |
CYP2C19, CYP2D6; CYP1A2, CYP2C9 |
|
|
Doxepin hydrochloride (USP) |
D00814 |
CYP2C19, CYP2D6; CYP1A2, CYP2C9 |
|
|
Dronedarone (INN) |
D02537 |
CYP3A |
CYP3A, CYP2D6 |
|
Dronedarone hydrochloride (USP) |
D03914 |
CYP3A |
CYP3A, CYP2D6 |
|
Droperidol and fentanyl citrate |
D03852 |
CYP3A4 |
|
|
Drospirenone (JAN/USP/INN) |
D03917 |
CYP3A4 |
|
|
Drospirenone and estetrol |
D12047 |
UGT2B7 |
|
|
Drospirenone and estradiol |
D12497 |
CYP3A4 |
|
|
Drospirenone and ethinylestradiol |
D09741 |
CYP3A4 |
|
|
Drospirenone, ethinyl estradiol and levomefolate calcium |
D12130 |
CYP3A4 |
|
|
Duloxetine (INN) |
D07880 |
CYP1A2; CYP2D6 |
CYP2D6 |
|
Duloxetine hydrochloride (JAN/USP) |
D01179 |
CYP1A2; CYP2D6 |
CYP2D6 |
|
Dutasteride (JAN/USP/INN) |
D03820 |
CYP3A4, CYP3A5 |
|
|
Dutasteride and tamsulosin |
D11389 |
CYP3A4, CYP3A5, CYP2D6 |
|
|
Dydrogesterone (JP18/USP/INN) |
D01217 |
CYP3A4 |
|
|
Ebastine (JP18/USAN/INN) |
D01478 |
CYP2J2, CYP3A4 |
|
|
Efavirenz (JAN/USP/INN) |
D00896 |
CYP3A4, CYP2B6 |
|
CYP2B6, CYP3A4 |
Elacestrant (USAN/INN) |
D11671 |
CYP3A4; CYP2A6, CYP2C9 |
|
|
Elacestrant hydrochloride (USAN) |
D11672 |
CYP3A4; CYP2A6, CYP2C9 |
|
|
Elafibranor (USAN) |
D11208 |
|
|
CYP3A4 |
Elagolix, estradiol and norethisterone |
D12137 |
CYP3A; CYP2D6, CYP2C8, UGT |
|
|
Elbasvir (JAN/USAN/INN) |
D10625 |
CYP3A |
|
|
Eletriptan (INN) |
D07887 |
CYP3A4 |
|
|
Eletriptan hydrobromide (JAN/USAN) |
D01973 |
CYP3A4 |
|
|
Eletriptan hydrobromide monohydrate |
D11617 |
CYP3A4 |
|
|
Elexacaftor, ivacaftor and tezacaftor |
D11700 |
CYP3A |
|
|
Eliglustat (USAN/INN) |
D09893 |
CYP2D6; CYP3A4 |
|
|
Eliglustat tartrate (JAN/USAN) |
D09894 |
CYP2D6; CYP3A4 |
|
|
Elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil |
D10756 |
CYP3A; CYP2D6 |
CYP3A, CYP2D6 |
|
Empagliflozin (JAN/USAN/INN) |
D10459 |
UGT2B7, UGT1A3, UGT1A8, UGT1A9 |
|
|
Emtricitabine and tenofovir alafenamide |
D10835 |
CTSA, CYP3A |
|
|
Emtricitabine, rilpivirine and tenofovir alafenamide |
D10836 |
CTSA, CYP3A |
|
|
Encainide (INN) |
D07894 |
CYP2D6 |
|
|
Encainide hydrochloride (USAN) |
D03991 |
CYP2D6 |
|
|
Encorafenib (JAN/USAN/INN) |
D11053 |
CYP3A4 |
|
|
Enflurane (JP18/USP/INN) |
D00543 |
CYP2E1 |
|
|
Enoxacin (USAN/INN) |
D00310 |
|
CYP1A2 |
|
Enoxacin hydrate (JP18) |
D05461 |
|
CYP1A2 |
|
Ensitrelvir (USAN/INN) |
D12619 |
CYP3A |
CYP3A |
|
Ensitrelvir fumarate (USAN) |
D12353 |
CYP3A |
CYP3A |
|
Entacapone (JP18/USP/INN) |
D00781 |
|
CYP2C9, COMT |
|
Entrectinib (JAN/USAN/INN) |
D10926 |
CYP3A4 |
CYP3A |
|
Enzalutamide (JAN/USAN) |
D10218 |
CYP2C8; CYP3A4 |
|
|
Epinephrine (USP/INN) |
D00095 |
COMT, MAO |
|
|
Epinephrine and lidocaine hydrochloride |
D04052 |
CYP1A2, CYP3A4 |
|
|
Epinephrine bitartrate (JAN/USP) |
D02149 |
COMT, MAO |
|
|
Epinephrine hydrochloride (JAN) |
D00996 |
COMT, MAO |
|
|
Eplerenone (JP18/USAN/INN) |
D01115 |
CYP3A4 |
|
|
Erdafitinib (JAN/USAN/INN) |
D10927 |
CYP2C9, CYP3A4 |
|
|
Ergoloid mesylates (USP) |
D02268 |
CYP3A4 |
|
|
Ergometrine (INN) |
D07905 |
CYP3A4 |
|
|
Ergonovine maleate (USP) |
D01163 |
CYP3A4 |
|
|
Ergotamine (INN) |
D07906 |
CYP3A4 |
|
|
Ergotamine tartrate (JP18/USP) |
D00679 |
CYP3A4 |
|
|
Eribulin mesylate (USAN) |
D08914 |
CYP3A4 |
|
|
Erlotinib (INN) |
D07907 |
CYP3A4, CYP1A2 |
|
|
Erlotinib hydrochloride (JAN/USAN) |
D04023 |
CYP3A4, CYP1A2 |
|
|
Ertugliflozin (USAN/INN) |
D10313 |
UGT1A9, UGT2B7 |
|
|
Ertugliflozin and sitagliptin |
D11066 |
UGT1A9, UGT2B7 |
|
|
Ertugliflozin pidolate |
D11043 |
UGT1A9, UGT2B7 |
|
|
Erythromycin (JP18/USP/INN) |
D00140 |
CYP3A |
CYP3A |
|
Erythromycin acistrate (USAN) |
D02523 |
CYP3A |
CYP3A |
|
Erythromycin estolate (USP) |
D00851 |
CYP3A |
CYP3A |
|
Erythromycin ethylsuccinate (JP18/USP) |
D01361 |
CYP3A |
CYP3A |
|
Erythromycin gluceptate (USP) |
D02524 |
CYP3A |
CYP3A |
|
Erythromycin lactobionate (JP18/USP) |
D02009 |
CYP3A |
CYP3A |
|
Erythromycin propionate (USAN) |
D02525 |
CYP3A |
CYP3A |
|
Erythromycin salnacedin (USAN) |
D04054 |
CYP3A |
CYP3A |
|
Erythromycin stearate (JP18/USP) |
D02184 |
CYP3A |
CYP3A |
|
Erythromycin stinoprate (INN) |
D07910 |
CYP3A |
CYP3A |
|
Erythromycin thiocyanate |
D07909 |
CYP3A |
CYP3A |
|
Esaxerenone (JAN/INN) |
D10892 |
CYP3A |
|
|
Escitalopram (INN) |
D07913 |
CYP3A4, CYP2C19, CYP2D6; MAO, AOX1 |
CYP2D6 |
|
Escitalopram oxalate (JAN/USP) |
D02567 |
CYP3A4, CYP2C19, CYP2D6; MAO, AOX1 |
CYP2D6 |
|
Esflurbiprofen (JAN) |
D10254 |
CYP2C9 |
|
|
Esflurbiprofen and mentha oil |
D10746 |
CYP2C9 |
|
|
Esketamine (USAN/INN) |
D07283 |
CYP2B6, CYP3A4; CYP2C9, CYP2C19, UGT |
|
|
Esketamine hydrochloride (JAN/USAN) |
D10627 |
CYP2B6, CYP3A4; CYP2C9, CYP2C19, UGT |
|
|
Eslicarbazepine (USAN/INN) |
D09215 |
|
CYP2C19 |
CYP3A4 |
Eslicarbazepine acetate (USAN) |
D09612 |
|
CYP2C19 |
CYP3A4 |
Esomeprazole (INN) |
D07917 |
CYP2C19; CYP3A4 |
|
|
Esomeprazole magnesium (USP) |
D01984 |
CYP2C19; CYP3A4 |
|
|
Esomeprazole magnesium dihydrate |
D11114 |
CYP2C19; CYP3A4 |
|
|
Esomeprazole potassium (USAN) |
D09339 |
CYP2C19; CYP3A4 |
|
|
Esomeprazole sodium (USAN) |
D04056 |
CYP2C19; CYP3A4 |
|
|
Esomeprazole strontium (USAN) |
D10120 |
CYP2C19; CYP3A4 |
|
|
Estazolam (JP18/USP/INN) |
D00311 |
CYP3A |
|
|
Estradiol (JAN/USP/INN) |
D00105 |
CYP3A4 |
|
|
Estradiol 17 beta-hemisuccinate |
D07919 |
CYP3A4 |
|
|
Estradiol acetate (USAN) |
D04061 |
CYP3A4 |
|
|
Estradiol and levonorgestrel |
D09187 |
CYP3A4 |
|
|
Estradiol and norethindrone |
D09188 |
CYP3A4 |
|
|
Estradiol benzoate (JP18/USP) |
D01953 |
CYP3A4 |
|
|
Estradiol cypionate (USP) |
D04063 |
CYP3A4 |
|
|
Estradiol dipropionate (JAN) |
D01617 |
CYP3A4 |
|
|
Estradiol enanthate (USAN) |
D04064 |
CYP3A4 |
|
|
Estradiol hemihydrate |
D07918 |
CYP3A4 |
|
|
Estradiol undecylate (USAN/INN) |
D04065 |
CYP3A4 |
|
|
Estradiol valerate (JAN/USP/INN) |
D01413 |
CYP3A4 |
|
|
Estrogens, conjugated (JAN/USP) |
D04070 |
CYP3A4 |
|
|
Estrone (JAN/USP/INN) |
D00067 |
CYP3A4 |
|
|
Estrone sodium sulfate |
D00312 |
CYP3A4 |
|
|
Estropipate (USP) |
D00948 |
CYP3A4 |
|
|
Eszopiclone (JAN/USP/INN) |
D02624 |
CYP3A4; CYP2E1 |
|
|
Ethinyl estradiol (USP) |
D00554 |
CYP3A4 |
CYP3A4 |
|
Ethinylestradiol propanesulfonate |
D07928 |
CYP3A4 |
CYP3A4 |
|
Ethosuximide (JP18/USP/INN) |
D00539 |
CYP3A4 |
|
|
Ethyl loflazepate (JP18/INN) |
D01293 |
CYP3A4 |
|
|
Ethylmorphine (BAN) |
D07929 |
CYP3A4 |
|
|
Ethylmorphine hydrochloride hydrate (JP18) |
D02205 |
CYP3A4 |
|
|
Etizolam (JP18/INN) |
D01514 |
CYP2C9, CYP3A4 |
|
|
Etrasimod (USAN) |
D10930 |
CYP2C8, CYP2C9, CYP3A4, UGT; CYP2C19, CYP2J2 |
|
|
Etrasimod arginine (USAN) |
D10931 |
CYP2C8, CYP2C9, CYP3A4, UGT; CYP2C19, CYP2J2 |
|
|
Etravirine (JAN/USAN/INN) |
D04112 |
CYP3A4, CYP2C9, CYP2C19 |
CYP2C9, CYP2C19 |
CYP3A4 |
Everolimus (JAN/USAN/INN) |
D02714 |
CYP3A4 |
|
|
Exemestane (JAN/USP/INN) |
D00963 |
CYP3A4 |
|
|
Ezetimibe (JAN/USP/INN) |
D01966 |
UGT |
|
|
Ezetimibe and atorvastatin |
D10385 |
CYP3A4 |
|
|
Ezetimibe and rosuvastatin |
D11520 |
UGT |
|
|
Famotidine (JP18/USP/INN) |
D00318 |
|
CYP1A2 |
|
Favipiravir (JAN/USAN/INN) |
D09537 |
AOX1; XDH |
CYP2C8, AOX1 |
|
Fedratinib (USAN/INN) |
D10630 |
CYP3A4, CYP2C19, FMO3 |
|
|
Fedratinib hydrochloride (USAN) |
D11296 |
CYP3A4, CYP2C19, FMO3 |
|
|
Felodipine (JP18/USP/INN) |
D00319 |
CYP3A4 |
|
|
Fenfluramine (INN) |
D07945 |
CYP1A2, CYP2B6, CYP2D6; CYP2C9, CYP2C19, CYP3A4, CYP3A5 |
|
|
Fenfluramine hydrochloride (JAN/USAN) |
D04148 |
CYP1A2, CYP2B6, CYP2D6; CYP2C9, CYP2C19, CYP3A4, CYP3A5 |
|
|
Fenofibrate (JP18/USP/INN) |
D00565 |
UGT |
|
|
Fentanyl (JAN/USP/INN) |
D00320 |
CYP3A4 |
|
|
Fentanyl citrate (JP18/USP) |
D01399 |
CYP3A4 |
|
|
Fentanyl hydrochloride (JAN) |
D10811 |
CYP3A4 |
|
|
Fesoterodine (INN) |
D07226 |
CYP2D6, CYP3A4 |
|
|
Fesoterodine fumarate (JAN/USAN) |
D08923 |
CYP2D6, CYP3A4 |
|
|
Fexinidazole (USAN/INN) |
D11252 |
CYP3A4 |
|
|
Fezolinetant (USAN) |
D11976 |
CYP1A2; CYP2C9, CYP2C19 |
|
|
Fidaxomicin (JAN/USAN) |
D09394 |
|
CYP2C19, CYP2C9, CYP3A4 |
|
Filgotinib (USAN/INN) |
D10871 |
CES1, CES2 |
|
|
Filgotinib hydrochloride (USAN) |
D10872 |
CES1, CES2 |
|
|
Filgotinib maleate (JAN/USAN) |
D11106 |
CES1, CES2 |
|
|
Finasteride (JAN/USP/INN) |
D00321 |
CYP3A4 |
|
|
Finasteride and tadalafil |
D12486 |
CYP3A4 |
|
|
Finerenone (JAN/USAN/INN) |
D10633 |
CYP3A4; CYP2C8 |
|
|
Fingolimod (INN) |
D10001 |
CYP4F2 |
|
|
Fingolimod hydrochloride (JAN/USAN) |
D04187 |
CYP4F2 |
|
|
Fingolimod lauryl sulfate |
D12549 |
CYP4F2 |
|
|
Flecainide (INN) |
D07962 |
CYP2D6 |
|
|
Flecainide acetate (JP18/USP) |
D00638 |
CYP2D6 |
|
|
Flibanserin (USAN/INN) |
D02577 |
CYP3A4; CYP2C19 |
|
|
Fluconazole (JP18/USP/INN) |
D00322 |
|
CYP2C19, CYP2C9, CYP3A4 |
|
Flunarizine (INN) |
D07971 |
CYP2D6 |
|
|
Flunarizine hydrochloride (JAN/USAN) |
D01303 |
CYP2D6 |
|
|
Flunisolide (JAN/USP) |
D00324 |
CYP3A4 |
|
|
Flunisolide acetate (USAN) |
D04214 |
CYP3A4 |
|
|
Fluorouracil (JP18/USP/INN) |
D00584 |
DPYD |
|
|
Fluorouracil sodium salt |
D07974 |
DPYD |
|
|
Fluoxetine (USAN/INN) |
D00326 |
CYP2C9, CYP2D6 |
CYP2C19, CYP2D6, CYP3A |
|
Fluoxetine hydrochloride (JAN/USP) |
D00823 |
CYP2C9, CYP2D6 |
CYP2C19, CYP2D6, CYP3A |
|
Fluphenazine (INN) |
D07977 |
CYP2D6 |
|
|
Fluphenazine decanoate (JAN/USP) |
D00793 |
CYP2D6 |
|
|
Fluphenazine enanthate (JP18/USP) |
D00792 |
CYP2D6 |
|
|
Fluphenazine hydrochloride (JAN/USP) |
D00791 |
CYP2D6 |
|
|
Fluphenazine maleate (JAN) |
D02163 |
CYP2D6 |
|
|
Flurbiprofen (JP18/USP/INN) |
D00330 |
CYP2C9 |
|
|
Flurbiprofen axetil (JAN) |
D01475 |
CYP2C9 |
|
|
Flurbiprofen sodium (USP) |
D02290 |
CYP2C9 |
|
|
Fluticasone (INN) |
D07981 |
CYP3A4 |
|
|
Fluticasone furoate (JAN/USAN/INN) |
D06315 |
CYP3A4 |
|
|
Fluticasone furoate and vilanterol trifenatate |
D10501 |
CYP3A4 |
|
|
Fluticasone propionate (JAN/USP) |
D01708 |
CYP3A4 |
|
|
Fluticasone propionate and formoterol fumarate hydrate |
D10506 |
CYP3A4, UGT |
|
|
Fluvastatin (INN) |
D07983 |
CYP2C9, CYP3A4 |
CYP2C9 |
|
Fluvastatin sodium (JAN/USP) |
D00892 |
CYP2C9, CYP3A4 |
CYP2C9 |
|
Fluvoxamine (INN) |
D07984 |
CYP2D6 |
CYP1A2, CYP2C19; CYP2C9, CYP2D6, CYP3A4 |
|
Fluvoxamine maleate (JP18/USP) |
D00824 |
CYP2D6 |
CYP1A2, CYP2C19; CYP2C9, CYP2D6, CYP3A4 |
|
Fomepizole (JAN/USAN/INN) |
D00707 |
|
CYP2D6, CYP2E1, CYP1A2, CYP2A6, CYP2C9, CYP3A4 |
|
Formoterol (INN) |
D07990 |
UGT |
|
|
Formoterol fumarate (USP) |
D01373 |
UGT |
|
|
Formoterol fumarate hydrate (JP18) |
D05277 |
UGT |
|
|
Fosamprenavir (INN) |
D02497 |
CYP3A4 |
CYP3A4 |
|
Fosamprenavir calcium (USAN) |
D03835 |
CYP3A4 |
CYP3A4 |
|
Fosamprenavir calcium hydrate (JAN) |
D02867 |
CYP3A4 |
CYP3A4 |
|
Fosamprenavir sodium (USAN) |
D03837 |
CYP3A4 |
CYP3A4 |
|
Fosaprepitant (INN) |
D10895 |
CYP3A4 |
CYP3A4 |
CYP3A4, CYP2C9 |
Fosaprepitant dimeglumine (USAN) |
D06597 |
CYP3A4 |
CYP3A4 |
CYP3A4, CYP2C9 |
Fosfluconazole (JAN/INN) |
D01429 |
|
CYP2C19, CYP2C9, CYP3A4 |
|
Foslevodopa and foscarbidopa |
D12494 |
COMT, DDC |
|
|
Fosnetupitant and palonosetron hydrochloride |
D10572 |
CYP3A4; CYP2C9, CYP2D6 |
|
|
Fosphenytoin (INN) |
D07993 |
CYP2C9; CYP2C19 |
|
CYP3A4, CYP2B6 |
Fosphenytoin sodium (USP) |
D02096 |
CYP2C9; CYP2C19 |
|
CYP3A4, CYP2B6 |
Fosphenytoin sodium hydrate (JAN) |
D07595 |
CYP2C9; CYP2C19 |
|
CYP3A4, CYP2B6 |
Fosravuconazole L-lysine ethanolate (JAN) |
D10762 |
|
CYP3A |
|
Fostamatinib (USAN) |
D09347 |
CYP3A4 |
CYP3A |
|
Fostamatinib disodium (USAN) |
D09348 |
CYP3A4 |
CYP3A |
|
Fostemsavir (USAN) |
D10707 |
CYP3A |
|
|
Fostemsavir tromethamine (USAN) |
D10708 |
CYP3A |
|
|
Fruquintinib (JAN/USAN) |
D11977 |
CYP3A; CYP2C8, CYP2C9, CYP2C19 |
|
|
Fulvestrant (JAN/USP/INN) |
D01161 |
CYP3A4 |
|
|
Galantamine (USAN/INN) |
D04292 |
CYP2D6, CYP3A4 |
|
|
Galantamine hydrobromide (JAN/USP) |
D02173 |
CYP2D6, CYP3A4 |
|
|
Ganaxolone (USAN/INN) |
D04300 |
CYP3A4, CYP3A5, CYP2B6, CYP2C19, CYP2D6 |
|
|
Gemfibrozil (JAN/USP/INN) |
D00334 |
|
CYP2C8 |
|
Gemtuzumab ozogamicin (USAN) |
D03259 |
CYP3A4 |
|
|
Gepirone hydrochloride (USAN) |
D04314 |
CYP3A4 |
|
|
Gilteritinib (USAN/INN) |
D10709 |
CYP3A4 |
|
|
Gilteritinib fumarate (JAN/USAN) |
D10800 |
CYP3A4 |
|
|
Glimepiride (JP18/USP/INN) |
D00593 |
CYP2C9 |
|
|
Glyburide (USP) |
D00336 |
CYP2C9, CYP3A4 |
|
|
Glycopyrronium bromide and indacaterol maleate |
D10505 |
CYP3A4 |
|
|
Granisetron (JAN/USAN/INN) |
D04370 |
CYP3A4, CYP1A1 |
|
|
Granisetron hydrochloride (JAN/USP) |
D00677 |
CYP3A4, CYP1A1 |
|
|
Grazoprevir (USAN) |
D10639 |
CYP3A |
CYP3A |
|
Grazoprevir (USAN/INN) |
D11565 |
CYP3A |
CYP3A |
|
Guanfacine (INN) |
D08031 |
CYP3A4, CYP3A5 |
|
|
Guanfacine hydrochloride (JAN/USP) |
D00606 |
CYP3A4, CYP3A5 |
|
|
Halofantrine (INN) |
D08033 |
|
CYP2D6 |
|
Halofantrine hydrochloride (USAN) |
D02485 |
|
CYP2D6 |
|
Haloperidol (JP18/USP/INN) |
D00136 |
CYP2D6, CYP3A4 |
|
|
Haloperidol decanoate (JAN/USP) |
D01898 |
CYP2D6, CYP3A4 |
|
|
Haloperidol lactate |
D08035 |
CYP2D6, CYP3A4 |
|
|
Halothane (JP18/USP/INN) |
D00542 |
CYP2E1, CYP3A4 |
|
|
Hemin (JAN) |
D10003 |
|
|
CYP3A4, CYP2D6 |
Hydralazine (INN) |
D08044 |
NAT |
CYP2D6 |
|
Hydralazine hydrochloride (JP18/USP) |
D01302 |
NAT |
CYP2D6 |
|
Hydralazine polistirex (USAN) |
D04458 |
NAT |
CYP2D6 |
|
Hydrocodone (INN) |
D08045 |
CYP3A4; CYP2D6, CYP2B6, CYP2C19 |
|
|
Hydrocodone bitartrate (USP) |
D03725 |
CYP3A4; CYP2D6, CYP2B6, CYP2C19 |
|
|
Hydrocodone hydrochloride |
D08046 |
CYP3A4; CYP2D6, CYP2B6, CYP2C19 |
|
|
Hydrocodone polistirex (USAN) |
D04461 |
CYP3A4; CYP2D6, CYP2B6, CYP2C19 |
|
|
Hydrocortisone (JP18/USP/INN) |
D00088 |
CYP3A |
|
|
Hydrocortisone aceponate (INN) |
D06876 |
CYP3A |
|
|
Hydrocortisone acetate (JP18/USP) |
D00165 |
CYP3A |
|
|
Hydrocortisone butyrate (JP18/USP) |
D01619 |
CYP3A |
|
|
Hydrocortisone caproate (JAN) |
D09796 |
CYP3A |
|
|
Hydrocortisone cypionate |
D00976 |
CYP3A |
|
|
Hydrocortisone hemisuccinate (USP) |
D04467 |
CYP3A |
|
|
Hydrocortisone probutate (USAN) |
D01886 |
CYP3A |
|
|
Hydrocortisone sodium phosphate (JP18/USP) |
D00977 |
CYP3A |
|
|
Hydrocortisone sodium succinate (JP18/USP) |
D00978 |
CYP3A |
|
|
Hydrocortisone succinate (JP18) |
D01442 |
CYP3A |
|
|
Hydrocortisone valerate (USP) |
D02288 |
CYP3A |
|
|
Hydromorphone (INN) |
D08047 |
UGT |
|
|
Hydromorphone hydrochloride (JAN/USP) |
D00839 |
UGT |
|
|
Hydroxychloroquine (INN) |
D08050 |
CYP2C8, CYP3A4 |
|
|
Hydroxychloroquine sulfate (JAN/USP) |
D02114 |
CYP2C8, CYP3A4 |
|
|
Ibrutinib (JAN/USAN) |
D10223 |
CYP3A |
|
|
Ibuprofen (JP18/USP/INN) |
D00126 |
CYP2C9 |
|
|
Ibuprofen aluminum (USAN) |
D04490 |
CYP2C9 |
|
|
Ibuprofen arginine salt |
D08058 |
CYP2C9 |
|
|
Ibuprofen lysine (USAN) |
D06606 |
CYP2C9 |
|
|
Ibuprofen piconol (JP18/USAN) |
D01122 |
CYP2C9 |
|
|
Ibuprofen sodium |
D08059 |
CYP2C9 |
|
|
Ibuprofen sodium (USAN) |
D09760 |
CYP2C9 |
|
|
Ibuprofen trelamine (USAN) |
D12597 |
CYP2C9 |
|
|
Ibuprofen trelamine hydrochloride (USAN) |
D12598 |
CYP2C9 |
|
|
Idelalisib (JAN/USAN/INN) |
D10560 |
CYP3A; UGT1A4 |
|
|
Ifosfamide (JAN/USP/INN) |
D00343 |
CYP3A4 |
|
|
Iguratimod (JAN/INN) |
D01146 |
NAT |
|
|
Iloperidone (USAN/INN) |
D02666 |
CYP3A4, CYP2D6 |
|
|
Imatinib (INN) |
D08066 |
CYP3A4 |
|
|
Imatinib mesylate (USAN) |
D01441 |
CYP3A4 |
|
|
Imidafenacin (JAN/INN) |
D06273 |
CYP3A4, UGT1A4 |
|
|
Imipramine (INN) |
D08070 |
CYP2D6; CYP1A2, CYP3A4, CYP2C19 |
|
|
Imipramine hydrochloride (JP18/USP) |
D00815 |
CYP2D6; CYP1A2, CYP3A4, CYP2C19 |
|
|
Imipramine pamoate (USP) |
D08071 |
CYP2D6; CYP1A2, CYP3A4, CYP2C19 |
|
|
Indacaterol (USAN/INN) |
D09318 |
CYP3A4 |
|
|
Indacaterol acetate (JAN) |
D11009 |
CYP3A4 |
|
|
Indacaterol maleate (JAN/USAN) |
D09319 |
CYP3A4 |
|
|
Indinavir (USAN) |
D03833 |
CYP3A4 |
CYP3A4 |
|
Indinavir sulfate (USP) |
D00897 |
CYP3A4 |
CYP3A4 |
|
Indinavir sulfate ethanolate (JAN) |
D02861 |
CYP3A4 |
CYP3A4 |
|
Insulin aspart (USP/INN) |
D04475 |
|
|
CYP1A2 |
Insulin detemir (USAN/INN) |
D04539 |
|
|
CYP1A2 |
Insulin glargine (USAN/INN) |
D03250 |
|
|
CYP1A2 |
Insulin glulisine (USAN/INN) |
D04540 |
|
|
CYP1A2 |
Insulin human (USP/INN) |
D03230 |
|
|
CYP1A2 |
Insulin injection, biphasic isophane (BAN) |
D08080 |
|
|
CYP1A2 |
Insulin lispro (USP/INN) |
D04477 |
|
|
CYP1A2 |
Insulin zinc (USP) |
D04551 |
|
|
CYP1A2 |
Insulin zinc, extended (USP) |
D04549 |
|
|
CYP1A2 |
Insulin zinc, prompt (USP) |
D04550 |
|
|
CYP1A2 |
Insulin, isophane (USP) |
D04547 |
|
|
CYP1A2 |
Ipragliflozin (INN) |
D10196 |
UGT2B7 |
|
|
Ipragliflozin L-proline (JAN) |
D10200 |
UGT2B7 |
|
|
Iptacopan (USAN/INN) |
D12251 |
CYP2C8; CYP2D6, UGT1A1, UGT1A3, UGT1A8 |
|
|
Iptacopan hydrochloride (USAN) |
D12252 |
CYP2C8; CYP2D6, UGT1A1, UGT1A3, UGT1A8 |
|
|
Irbesartan (JP18/USP/INN) |
D00523 |
CYP2C9 |
|
|
Irbesartan and amlodipine besilate (JP18) |
D10243 |
CYP3A4 |
|
|
Irbesartan and trichlormethiazide |
D10480 |
CYP2C9, UGT |
|
|
Irinotecan (INN) |
D08086 |
CES; CYP3A4, UGT1A1 |
|
|
Irinotecan hydrochloride (USP) |
D01061 |
CES; CYP3A4, UGT1A1 |
|
|
Irinotecan sucrosofate (USAN) |
D10642 |
CES; CYP3A4, UGT1A1 |
|
|
Isavuconazonium (USAN) |
D10644 |
CYP3A |
CYP3A, UGT |
CYP2B6 |
Isavuconazonium sulfate (JAN/USAN) |
D10643 |
CYP3A |
CYP3A, UGT |
CYP2B6 |
Isoprenaline (INN) |
D08090 |
COMT |
|
|
Isopropylantipyrine, ergotamine tartrate and anhydrous caffeine |
D07585 |
CYP3A4 |
|
|
Isoproterenol hydrochloride (USP) |
D01390 |
COMT |
|
|
Isoproterenol sulfate (USP) |
D02066 |
COMT |
|
|
Istradefylline (JAN/USAN/INN) |
D04641 |
CYP1A1, CYP3A4, CYP3A5 |
CYP3A4, CYP3A5 |
|
Itopride (INN) |
D08094 |
FMO1, FMO3 |
|
|
Itopride hydrochloride (JAN) |
D02729 |
FMO1, FMO3 |
|
|
Itraconazole (JP18/USP) |
D00350 |
CYP3A4 |
CYP3A4 |
|
Ivabradine (USAN/INN) |
D07165 |
CYP3A4 |
|
|
Ivabradine hydrochloride (JAN/USAN) |
D08095 |
CYP3A4 |
|
|
Ivermectin (JAN/USP/INN) |
D00804 |
CYP3A4 |
|
|
Ixabepilone (JAN/USAN/INN) |
D04645 |
CYP3A4 |
|
|
Josamycin (JP18/USAN/INN) |
D01235 |
|
CYP3A4 |
|
Josamycin propionate (JP18) |
D05351 |
|
CYP3A4 |
|
Ketoconazole (JP18/USP) |
D00351 |
CYP3A4 |
CYP3A4 |
|
Lacosamide (JAN/USAN/INN) |
D07299 |
CYP3A4, CYP2C9, CYP2C19 |
CYP2C19 |
|
Lafutidine (JP18/INN) |
D01131 |
CYP3A4, CYP2D6 |
|
|
Lamivudine, nevirapine and zidovudine |
D11521 |
CYP3A, CYP2B6, UGT |
|
CYP3A, CYP2B6 |
Lamotrigine (JAN/USP/INN) |
D00354 |
UGT1A4 |
|
|
Lanoconazole (JP18/INN) |
D01092 |
|
CYP2C9 |
|
Lansoprazole (JP18/USP/INN) |
D00355 |
CYP2C19, CYP3A4 |
CYP2C19 |
|
Lansoprazole, amoxicillin hydrate and metronidazole |
D09742 |
CYP2C19, CYP3A4 |
|
|
Lapatinib (INN) |
D08108 |
CYP3A4, CYP3A5; CYP2C19, CYP2C8 |
|
|
Lapatinib ditosylate (USAN) |
D04024 |
CYP3A4, CYP3A5; CYP2C19, CYP2C8 |
|
|
Larotrectinib (USAN/INN) |
D11137 |
CYP3A |
|
|
Larotrectinib sulfate (JAN/USAN) |
D11138 |
CYP3A |
|
|
Lazertinib (USAN/INN) |
D11980 |
CYP3A4 |
|
|
Lazertinib mesylate (USAN) |
D12245 |
CYP3A4 |
|
|
Lefamulin (USAN/INN) |
D11631 |
CYP3A4 |
|
|
Lefamulin acetate (USAN) |
D11632 |
CYP3A4 |
|
|
Leflunomide (JAN/USP/INN) |
D00749 |
CYP3A4 |
CYP2C9 |
|
Lemborexant (JAN/USAN/INN) |
D11022 |
CYP3A4; CYP3A5 |
|
|
Lenacapavir (USAN/INN) |
D12161 |
UGT1A1, CYP3A |
|
|
Lenacapavir sodium (JAN/USAN) |
D12162 |
UGT1A1, CYP3A |
|
|
Leniolisib (USAN/INN) |
D11158 |
CYP3A4 |
|
|
Leniolisib phosphate (JAN/USAN) |
D11159 |
CYP3A4 |
|
|
Lenvatinib (USAN/INN) |
D09919 |
CYP3A |
|
|
Lenvatinib mesylate (USAN) |
D09920 |
CYP3A |
|
|
Lercanidipine (INN) |
D08111 |
CYP3A |
|
|
Lercanidipine hydrochloride (JAN/USAN) |
D01849 |
CYP3A |
|
|
Lesinurad (USAN/INN) |
D09921 |
CYP2C9 |
|
|
Lesinurad sodium (USAN) |
D09922 |
CYP2C9 |
|
|
Letermovir (JAN/USAN/INN) |
D10801 |
|
CYP3A |
CYP2C9, CYP2C19 |
Letrozole (JAN/USP/INN) |
D00964 |
CYP3A4, CYP2A6 |
CYP2A6 |
|
Levobupivacaine (INN) |
D08116 |
CYP3A4, CYP1A2 |
|
|
Levobupivacaine hydrochloride (JAN/USAN) |
D01287 |
CYP3A4, CYP1A2 |
|
|
Levocetirizine (USAN/INN) |
D07402 |
CYP3A4 |
|
|
Levocetirizine dihydrochloride (USP) |
D08118 |
CYP3A4 |
|
|
Levomethadyl acetate (USAN) |
D04716 |
CYP3A4 |
|
|
Levomethadyl acetate hydrochloride (USAN) |
D00840 |
CYP3A4 |
|
|
Lidocaine (JP18/USP/INN) |
D00358 |
CYP1A2, CYP3A4 |
|
|
Lidocaine and prilocaine |
D02740 |
CYP1A2, CYP3A4 |
|
|
Lidocaine and tetracaine |
D11553 |
CYP1A2; CYP3A4 |
|
|
Lidocaine hydrochloride (JAN/USP) |
D02086 |
CYP1A2, CYP3A4 |
|
|
Lidocaine hydrochloride and epinephrine bitartrate |
D04813 |
CYP1A2, CYP3A4 |
|
|
Lidocaine hydrochloride monohydrate |
D08127 |
CYP1A2, CYP3A4 |
|
|
Lomitapide (USAN/INN) |
D09637 |
CYP3A4 |
|
|
Lomitapide mesylate (USAN) |
D09638 |
CYP3A4 |
|
|
Loperamide (INN) |
D08144 |
CYP3A4, CYP2C8 |
|
|
Loperamide hydrochloride (JAN/USP) |
D00729 |
CYP3A4, CYP2C8 |
|
|
Loperamide oxide (INN) |
D07113 |
CYP3A4, CYP2C8 |
|
|
Lopinavir (JAN/USP/INN) |
D01425 |
CYP3A |
CYP3A |
|
Lopinavir and ritonavir |
D02498 |
CYP3A |
CYP3A |
|
Loratadine (JAN/USP/INN) |
D00364 |
CYP2D6, CYP3A4 |
|
|
Lorazepam (JP18/USP/INN) |
D00365 |
UGT2B7, UGT2B15 |
|
|
Lorlatinib (JAN/USAN/INN) |
D11012 |
CYP3A |
|
CYP3A |
Lornoxicam (JP18/USAN/INN) |
D01866 |
CYP2C9 |
|
|
Losartan (INN) |
D08146 |
CYP2C9 |
|
|
Losartan potassium (JP18/USP) |
D00357 |
CYP2C9 |
|
|
Losartan potassium and hydrochlorothiazide (JP18) |
D07895 |
CYP2C9 |
|
|
Lovastatin (USP/INN) |
D00359 |
CYP3A4 |
|
|
Loxapine (USAN/INN) |
D02340 |
CYP1A2, CYP3A4, CYP2D6 |
|
|
Loxapine hydrochloride |
D08148 |
CYP1A2, CYP3A4, CYP2D6 |
|
|
Loxapine succinate (USP) |
D00794 |
CYP1A2, CYP3A4, CYP2D6 |
|
|
Luliconazole (JAN/USAN/INN) |
D01980 |
|
CYP2B6, CYP2C8, CYP2C19, CYP3A4 |
|
Lurasidone hydrochloride (JAN/USAN) |
D04820 |
CYP3A4 |
|
|
Lusutrombopag (JAN/USAN/INN) |
D10476 |
CYP4A11 |
|
|
Macitentan (JAN/USAN) |
D10135 |
CYP3A4 |
|
|
Macitentan and tadalafil |
D12963 |
CYP3A; CYP2C8, CYP2C9, CYP2C19 |
|
|
Manidipine (INN) |
D08155 |
CYP3A4 |
|
|
Manidipine hydrochloride (JP18) |
D01553 |
CYP3A4 |
|
|
Maprotiline (USAN) |
D02566 |
CYP2D6 |
|
|
Maprotiline hydrochloride (JP18/USP) |
D00818 |
CYP2D6 |
|
|
Maraviroc (JAN/INN) |
D06670 |
CYP3A4 |
|
|
Maribavir (JAN/USAN/INN) |
D04859 |
CYP3A4; CYP1A2 |
|
|
Mavacamten (JAN/USAN/INN) |
D12265 |
CYP2C19; CYP3A4, CYP2C9 |
|
|
Mavorixafor (USAN) |
D11510 |
CYP3A4; CYP2D6 |
|
|
Maxacalcitol (JAN/USAN/INN) |
D01098 |
CYP3A4 |
|
|
Mefenamic acid (JP18/USP/INN) |
D00151 |
CYP2C9 |
|
|
Mefloquine (USAN/INN) |
D04895 |
CYP3A |
|
|
Mefloquine hydrochloride (JP18/USP) |
D00831 |
CYP3A |
|
|
Melatonin (JAN) |
D08170 |
CYP1A2 |
|
|
Meloxicam (JAN/USP/INN) |
D00969 |
CYP2C9; CYP3A4 |
|
|
Mepenzolate bromide and phenobarbital |
D04059 |
|
|
CYP3A |
Mephenytoin (USP/INN) |
D00375 |
CYP2C19 |
|
|
Mephobarbital (JAN/USP) |
D00700 |
CYP2C19 |
|
|
Mequitazine (JP18/INN) |
D01324 |
CYP2D6 |
|
|
Metamfetamine (INN) |
D08187 |
CYP2D6 |
|
|
Metformin hydrochloride and saxagliptin hydrochloride |
D10263 |
CYP3A4, CYP3A5 |
|
|
Methadone (BAN) |
D08195 |
CYP3A4, CYP2B6; CYP2C8, CYP2C9, CYP2C19, CYP2D6 |
|
CYP3A4, CYP2B6 |
Methadone hydrochloride (JAN/USP) |
D02102 |
CYP3A4, CYP2B6; CYP2C8, CYP2C9, CYP2C19, CYP2D6 |
|
CYP3A4, CYP2B6 |
Methamphetamine hydrochloride (JP18/USP) |
D02242 |
CYP2D6 |
|
|
Methoxsalen (JP18/USP) |
D00139 |
|
CYP2A6 |
|
Methoxyflurane (USP/INN) |
D00544 |
CYP2E1, CYP3A4 |
|
|
Methylene blue (USP) |
D02312 |
|
CYP1A2, CYP2B6, CYP2C9, CYP2C19 |
|
Methylergometrine (INN) |
D08207 |
CYP3A4 |
|
|
Methylergonovine maleate (USP) |
D00680 |
CYP3A4 |
|
|
Methylprednisolone (JP18/USP/INN) |
D00407 |
CYP3A4 |
|
|
Methylprednisolone aceponate (INN) |
D07203 |
CYP3A4 |
|
|
Methylprednisolone acetate (JAN/USP) |
D00979 |
CYP3A4 |
|
|
Methylprednisolone hemisuccinate (USP) |
D05000 |
CYP3A4 |
|
|
Methylprednisolone sodium phosphate (USAN) |
D05001 |
CYP3A4 |
|
|
Methylprednisolone sodium succinate (JAN/USP) |
D00751 |
CYP3A4 |
|
|
Methylprednisolone suleptanate (USAN/INN) |
D05002 |
CYP3A4 |
|
|
Methylthioninium chloride hydrate (JAN) |
D10537 |
|
CYP1A2, CYP2B6, CYP2C9, CYP2C19 |
|
Metoclopramide (JP18/INN) |
D00726 |
CYP2D6 |
CYP2D6 |
|
Metoclopramide hydrochloride (JAN) |
D02213 |
CYP2D6 |
CYP2D6 |
|
Metoclopramide hydrochloride (USP) |
D05008 |
CYP2D6 |
CYP2D6 |
|
Metoprolol (USAN/INN) |
D02358 |
CYP2D6 |
|
|
Metoprolol and hydrochlorothiazide |
D10273 |
CYP2D6 |
|
|
Metoprolol fumarate (USP) |
D05011 |
CYP2D6 |
|
|
Metoprolol succinate (USP) |
D00635 |
CYP2D6 |
|
|
Metoprolol tartrate (JP18/USP) |
D00601 |
CYP2D6 |
|
|
Metronidazole (JP18/USP/INN) |
D00409 |
CYP2A6 |
CYP2C9 |
|
Metronidazole benzoate (USP) |
D08214 |
CYP2A6 |
CYP2C9 |
|
Metronidazole hydrochloride (USAN) |
D05016 |
CYP2A6 |
CYP2C9 |
|
Metronidazole phosphate (USAN) |
D05017 |
CYP2A6 |
CYP2C9 |
|
Mexazolam (JAN/INN) |
D01316 |
CYP3A4 |
|
|
Mexiletine (INN) |
D08215 |
CYP1A2, CYP2D6 |
|
|
Mexiletine hydrochloride (JP18/USP) |
D00639 |
CYP1A2, CYP2D6 |
|
|
Mianserin (INN) |
D08216 |
CYP3A4, CYP1A2, CYP2D6 |
|
|
Mianserin hydrochloride (JAN/USAN) |
D01358 |
CYP3A4, CYP1A2, CYP2D6 |
|
|
Mibefradil (INN) |
D08217 |
|
CYP3A, CYP1A2, CYP2D6 |
|
Mibefradil dihydrochloride (USAN) |
D05024 |
|
CYP3A, CYP1A2, CYP2D6 |
|
Miconazole (JP18/USP/INN) |
D00416 |
|
CYP2C9, CYP3A |
|
Miconazole nitrate (JP18/USP) |
D00882 |
|
CYP2C9, CYP3A |
|
Midazolam (JAN/USP/INN) |
D00550 |
CYP3A4 |
|
|
Midazolam hydrochloride (USAN) |
D00696 |
CYP3A4 |
|
|
Midazolam maleate (USAN) |
D05028 |
CYP3A4 |
|
|
Midecamycin (JP18/INN) |
D01339 |
|
CYP3A4 |
|
Midecamycin acetate (JP18) |
D01636 |
|
CYP3A4 |
|
Midodrine (INN) |
D08220 |
|
CYP2D6 |
|
Midodrine hydrochloride (JAN/USP) |
D01307 |
|
CYP2D6 |
|
Midostaurin (JAN/USAN/INN) |
D05029 |
CYP3A4 |
|
|
Mifepristone (JAN/USAN/INN) |
D00585 |
CYP3A4 |
CYP3A |
|
Mifepristone and misoprostol |
D12586 |
CYP3A |
CYP3A |
|
Milrinone (JAN/USP/INN) |
D00417 |
UGT |
|
|
Milrinone lactate |
D02085 |
UGT |
|
|
Minaprine (USAN/INN) |
D05039 |
CYP2D6 |
|
|
Minaprine hydrochloride (USAN) |
D05040 |
CYP2D6 |
|
|
Mirabegron (JAN/USAN/INN) |
D09535 |
CYP3A4 |
CYP2D6 |
|
Mirtazapine (JAN/USP/INN) |
D00563 |
CYP1A2, CYP2D6, CYP3A4 |
|
|
Mirtazapine hydrate (JAN) |
D11056 |
CYP1A2, CYP2D6, CYP3A4 |
|
|
Mirvetuximab soravtansine (USAN/INN) |
D10954 |
CYP3A4 |
|
|
Mitiglinide calcium hydrate (JP18) |
D01854 |
UGT |
|
|
Mobocertinib (USAN/INN) |
D12001 |
CYP3A |
|
|
Mobocertinib succinate (JAN) |
D11969 |
CYP3A |
|
|
Moclobemide (USAN/INN) |
D02561 |
CYP2C19 |
CYP2D6, CYP2C19 |
|
Modafinil (JAN/USP/INN) |
D01832 |
CYP3A4 |
CYP2C9, CYP2C19 |
CYP1A2, CYP2B6, CYP3A4 |
Mofezolac (JAN/INN) |
D01718 |
CYP2C9 |
|
|
Momelotinib (USAN/INN) |
D10315 |
CYP3A4, CYP2C8, CYP2C9, CYP2C19, CYP1A2 |
|
|
Momelotinib dihydrochloride (USAN) |
D10358 |
CYP3A4, CYP2C8, CYP2C9, CYP2C19, CYP1A2 |
|
|
Momelotinib hydrochloride hydrate (JAN) |
D10889 |
CYP3A4, CYP2C8, CYP2C9, CYP2C19, CYP1A2 |
|
|
Mometasone (INN) |
D08227 |
CYP3A4 |
|
|
Mometasone furoate (JAN/USP) |
D00690 |
CYP3A4 |
|
|
Mometasone furoate hydrate (JAN) |
D03325 |
CYP3A4 |
|
|
Montelukast (INN) |
D08229 |
CYP2C8, CYP2C9, CYP3A4 |
|
|
Montelukast sodium (JP18/USP) |
D00529 |
CYP2C8, CYP2C9, CYP3A4 |
|
|
Moricizine (USAN) |
D05077 |
|
|
CYP1A2 |
Moricizine hydrochloride (USP) |
D02087 |
|
|
CYP1A2 |
Morphine (BAN) |
D08233 |
UGT |
|
|
Morphine hydrochloride hydrate (JP18) |
D02271 |
UGT |
|
|
Morphine sulfate (USP) |
D00842 |
UGT |
|
|
Morphine tartrate |
D08234 |
UGT |
|
|
Mosapride (INN) |
D08236 |
CYP3A4 |
|
|
Mosapride citrate hydrate (JP18) |
D01994 |
CYP3A4 |
|
|
Mozavaptane hydrochloride (JAN) |
D01855 |
CYP3A4, CYP2C8 |
|
|
Naldemedine (USAN/INN) |
D10188 |
CYP3A4 |
|
|
Naldemedine tosylate (JAN/USAN) |
D10478 |
CYP3A4 |
|
|
Nalfurafine hydrochloride (JAN/USAN) |
D06405 |
CYP3A4 |
|
|
Naloxegol (USAN/INN) |
D10479 |
CYP3A |
|
|
Naloxegol oxalate (USAN) |
D10375 |
CYP3A |
|
|
Naproxen and esomeprazole magnesium |
D11576 |
CYP2C9, CYP1A2, CYP2C19; CYP3A4 |
|
|
Naratriptan (INN) |
D08255 |
CYP1A2, CYP2C9, CYP2D6, CYP2E1, CYP3A4, CYP3A5 |
|
|
Naratriptan hydrochloride (JAN/USP) |
D00674 |
CYP1A2, CYP2C9, CYP2D6, CYP2E1, CYP3A4, CYP3A5 |
|
|
Nateglinide (JP18/USP/INN) |
D01111 |
CYP2C9 |
|
|
Nebivolol (USAN/INN) |
D05127 |
CYP2D6 |
|
|
Nebivolol hydrochloride (USAN) |
D06622 |
CYP2D6 |
|
|
Nelarabine (JAN/USAN/INN) |
D05134 |
ADA |
|
|
Nelfinavir (INN) |
D08259 |
CYP3A4; CYP2C19 |
CYP3A4 |
|
Nelfinavir mesylate (USAN/INN) |
D00899 |
CYP3A4; CYP2C19 |
CYP3A4 |
|
Nemonapride (JAN/INN) |
D01468 |
CYP3A4 |
|
|
Neratinib (USAN/INN) |
D08950 |
CYP3A4; FMO |
|
|
Neratinib maleate |
D10898 |
CYP3A4; FMO |
|
|
Netupitant (USAN/INN) |
D05152 |
CYP3A |
CYP3A |
|
Nevirapine (JAN/USP/INN) |
D00435 |
CYP3A4, CYP2B6, CYP2D6 |
|
|
Nicardipine (INN) |
D08270 |
CYP3A4 |
|
|
Nicardipine hydrochloride (JP18/USAN) |
D00617 |
CYP3A4 |
|
|
Nicotine (USP) |
D03365 |
CYP2A6 |
|
CYP1A2 |
Nicotine bitartrate (USAN) |
D05156 |
CYP2A6 |
|
CYP1A2 |
Nicotine polacrilex (USP) |
D05157 |
CYP2A6 |
|
CYP1A2 |
Nifedipine (JP18/USP/INN) |
D00437 |
CYP3A4 |
|
|
Nilotinib (USAN/INN) |
D08953 |
CYP3A4; CYP2C8 |
|
|
Nilotinib hydrochloride dihydrate (JAN) |
D12444 |
CYP3A4; CYP2C8 |
|
|
Nilotinib hydrochloride hydrate (JAN) |
D06413 |
CYP3A4; CYP2C8 |
|
|
Nilotinib laurylsulfate (USAN) |
D12854 |
CYP3A4; CYP2C8 |
|
|
Nilvadipine (JP18/USAN/INN) |
D01908 |
CYP3A4 |
|
|
Nimodipine (USP/INN) |
D00438 |
CYP3A4 |
|
|
Nintedanib (USAN/INN) |
D10481 |
UGT |
|
|
Nintedanib esylate (USAN) |
D10396 |
UGT |
|
|
Nirmatrelvir and ritonavir |
D12269 |
CYP3A4 |
CYP3A |
|
Nirogacestat (USAN/INN) |
D10960 |
CYP3A4; CYP2C19, CYP2C9, CYP2D6 |
|
|
Nirogacestat hydrobromide (USAN) |
D11453 |
CYP3A4; CYP2C19, CYP2C9, CYP2D6 |
|
|
Nisoldipine (JAN/USAN/INN) |
D00618 |
CYP3A4 |
|
|
Nitisinone (JAN/USAN/INN) |
D05177 |
|
CYP2C9 |
|
Nitrendipine (JP18/USAN/INN) |
D00629 |
CYP3A4 |
|
|
Noradrenaline (JP18) |
D00076 |
COMT, MAO |
|
|
Nordazepam (INN) |
D08283 |
CYP2C19, CYP3A4 |
|
|
Norepinephrine bitartrate (USP) |
D05206 |
COMT, MAO |
|
|
Norepinephrine hydrochloride (JAN) |
D09794 |
COMT, MAO |
|
|
Norepinephrine hydrochoride |
D08284 |
COMT, MAO |
|
|
Norfloxacin (JP18/USP/INN) |
D00210 |
CYP1A2 |
CYP3A, CYP1A2 |
|
Norfloxacin nicotinate |
D08287 |
CYP1A2 |
CYP3A, CYP1A2 |
|
Norgestrel and ethinylestradiol tablets (JP18) |
D04463 |
CYP3A4, CYP2C9, CYP2C19 |
|
|
Nortriptyline (INN) |
D08288 |
CYP2D6 |
|
|
Nortriptyline hydrochloride (JP18/USP/INN) |
D00816 |
CYP2D6 |
|
|
Ofloxacin (JP18/USP/INN) |
D00453 |
CYP3A4 |
|
|
Ofloxacin hydrochloride |
D08291 |
CYP3A4 |
|
|
Olanzapine (JAN/USP/INN) |
D00454 |
CYP1A2; CYP2D6 |
|
|
Olanzapine pamoate (USAN) |
D06623 |
CYP1A2; CYP2D6 |
|
|
Olaparib (JAN/USAN/INN) |
D09730 |
CYP3A |
|
|
Olmesartan medoxomil and azelnidipine |
D09594 |
CYP3A4 |
|
|
Olodaterol (USAN/INN) |
D10145 |
CYP2C9, CYP2C8, UGT2B7, UGT1A1, UGT1A7, UGT1A9 |
|
|
Olodaterol hydrochloride (JAN/USAN) |
D10020 |
CYP2C9, CYP2C8, UGT2B7, UGT1A1, UGT1A7, UGT1A9 |
|
|
Olutasidenib (USAN/INN) |
D12483 |
CYP3A4 |
|
|
Omaveloxolone (USAN/INN) |
D10964 |
CYP3A; CYP2C8, CYP2J2 |
|
|
Ombitasvir, paritaprevir and ritonavir |
D10745 |
CYP3A4, CYP3A5 |
CYP3A4 |
|
Omeprazole (JP18/USP/INN) |
D00455 |
CYP2C19; CYP3A4 |
|
|
Omeprazole and sodium bicarbonate |
D11706 |
CYP2C19; CYP3A4 |
|
|
Omeprazole magnesium (USP) |
D05259 |
CYP2C19; CYP3A4 |
|
|
Omeprazole magnesium, amoxicillin and rifabutin |
D11858 |
CYP3A, CYP2C19 |
CYP2C19 |
CYP3A |
Omeprazole sodium (USAN) |
D01207 |
CYP2C19; CYP3A4 |
|
|
Omeprazole sodium injection (JAN) |
D05261 |
CYP2C19; CYP3A4 |
|
|
Omeprazole, clarithromycin and amoxicillin |
D10246 |
CYP2C19, CYP3A4 |
CYP3A4 |
|
Omidenepag (USAN/INN) |
D10965 |
CES1 |
|
|
Omidenepag isopropyl (JAN) |
D10966 |
CES1 |
|
|
Ondansetron (JAN/USP/INN) |
D00456 |
CYP1A2, CYP3A4, CYP2D6 |
|
|
Ondansetron hydrochloride hydrate (JAN/USP) |
D00678 |
CYP1A2, CYP2D6, CYP3A4 |
|
|
Opicapone (JAN/USAN/INN) |
D10825 |
|
COMT |
|
Osilodrostat (USAN/INN) |
D11061 |
CYP3A4, CYP2B6, CYP2D6, UGT |
|
|
Osilodrostat phosphate (JAN/USAN) |
D11062 |
CYP3A4, CYP2B6, CYP2D6, UGT |
|
|
Osimertinib mesylate (USAN) |
D10766 |
CYP3A |
|
|
Oxcarbazepine (JAN/USP/INN) |
D00533 |
|
CYP2C19 |
CYP3A |
Oxtriphylline (USP) |
D02017 |
CYP1A2 |
|
|
Oxybutynin (USAN/INN) |
D00465 |
CYP3A4, CYP3A5 |
|
|
Oxybutynin chloride (USP) |
D00722 |
CYP3A4, CYP3A5 |
|
|
Oxycodone (USAN/INN) |
D05312 |
CYP3A4; CYP2D6 |
|
|
Oxycodone and ibuprofen |
D11573 |
CYP3A4, CYP2A6 |
|
|
Oxycodone hydrochloride (USP) |
D00847 |
CYP3A4; CYP2D6 |
|
|
Oxycodone hydrochloride hydrate (JP18) |
D05462 |
CYP3A4; CYP2D6 |
|
|
Oxycodone terephthalate (USP) |
D03783 |
CYP3A4; CYP2D6 |
|
|
Ozenoxacin (JAN/USAN/INN) |
D09544 |
CYP3A4 |
|
|
Paclitaxel (JAN/USP/INN) |
D00491 |
CYP2C8, CYP3A4 |
|
|
Paclitaxel poliglumex (USAN/INN) |
D05333 |
CYP2C8, CYP3A4 |
|
|
Pacritinib (USAN/INN) |
D11768 |
CYP3A4 |
|
|
Palonosetron (INN) |
D07175 |
CYP1A2, CYP2D6, CYP3A4 |
|
|
Palonosetron hydrochloride (JAN/USP) |
D05343 |
CYP1A2, CYP2D6, CYP3A4 |
|
|
Palovarotene (JAN/USAN/INN) |
D09365 |
CYP3A4; CYP2C8, CYP2C19 |
|
|
Panobinostat (USAN/INN) |
D10319 |
CYP3A4 |
CYP2D6 |
|
Panobinostat lactate (JAN) |
D10019 |
CYP3A4 |
CYP2D6 |
|
Pantoprazole (USAN/INN) |
D05353 |
CYP2C19; CYP3A4 |
|
|
Pantoprazole sodium (USP) |
D02593 |
CYP2C19; CYP3A4 |
|
|
Paroxetine (USP/INN) |
D02362 |
CYP2D6 |
CYP2D6 |
|
Paroxetine hydrochloride (USP) |
D05374 |
CYP2D6 |
CYP2D6 |
|
Paroxetine hydrochloride hemihydrate (USP) |
D02260 |
CYP2D6 |
CYP2D6 |
|
Paroxetine mesylate (USAN) |
D05375 |
CYP2D6 |
CYP2D6 |
|
Pazufloxacin (JAN/INN) |
D01153 |
|
CYP1A2 |
|
Pazufloxacin mesilate (JP18) |
D05382 |
|
CYP1A2 |
|
Peginterferon alfa-2b (USAN/INN) |
D02748 |
|
CYP1A2, CYP2D6 |
|
Pemafibrate (JAN) |
D10711 |
CYP3A, CYP2C9, CYP2C8 |
|
|
Pemigatinib (JAN/USAN/INN) |
D11417 |
CYP3A4 |
|
|
Perampanel (USAN) |
D08964 |
CYP3A |
|
|
Perampanel hydrate (JAN) |
D10780 |
CYP3A |
|
|
Perhexiline (INN) |
D08340 |
CYP2D6 |
|
|
Perhexiline maleate (USAN) |
D05442 |
CYP2D6 |
|
|
Perphenazine (JP18/USP/INN) |
D00503 |
CYP2D6 |
|
|
Perphenazine decanoate |
D08341 |
CYP2D6 |
|
|
Perphenazine enantate |
D08342 |
CYP2D6 |
|
|
Perphenazine fendizoate (JAN) |
D04038 |
CYP2D6 |
|
|
Perphenazine hydrochloride |
D04965 |
CYP2D6 |
|
|
Perphenazine maleate (JP18) |
D02037 |
CYP2D6 |
|
|
Pexidartinib (USAN/INN) |
D11270 |
CYP3A4, UGT1A4 |
|
|
Pexidartinib hydrochloride (JAN/USAN) |
D11271 |
CYP3A4, UGT1A4 |
|
|
Phenformin (BAN) |
D08351 |
CYP2D6 |
|
|
Phenformin hydrochloride |
D08352 |
CYP2D6 |
|
|
Phenobarbital (JP18/USP/INN) |
D00506 |
|
|
CYP3A; CYP1A2, CYP2B6, CYP2C9 |
Phenobarbital diethylamine |
D08356 |
|
|
CYP3A; CYP1A2, CYP2B6, CYP2C9 |
Phenobarbital sodium (JAN/USP/INN) |
D00701 |
|
|
CYP3A; CYP1A2, CYP2B6, CYP2C9 |
Phentermine and topiramate |
D11710 |
CYP3A4 |
|
|
Phenylbutazone (JP18/USP/INN) |
D00510 |
|
CYP2C9 |
|
Phenylbutazone calcium |
D08363 |
|
CYP2C9 |
|
Phenylbutazone sodium |
D08364 |
|
CYP2C9 |
|
Phenylpropanolamine (INN) |
D08368 |
|
CYP1A2 |
|
Phenylpropanolamine hydrochloride (JAN/USP) |
D01224 |
|
CYP1A2 |
|
Phenylpropanolamine polistirex (USAN) |
D05466 |
|
CYP1A2 |
|
Phenytoin (JP18/USP/INN) |
D00512 |
CYP2C9; CYP2C19 |
|
CYP3A, CYP2B6 |
Phenytoin and phenobarbital |
D07583 |
CYP2C9; CYP2C19 |
|
CYP3A, CYP2B6 |
Phenytoin sodium (USP) |
D02103 |
CYP2C9; CYP2C19 |
|
CYP3A, CYP2B6 |
Phenytoin, phenobarbital and caffeine and sodium benzoate |
D03844 |
CYP2C9, CYP2C19, CYP2B6, CYP3A |
|
|
Pilocarpine (JAN/USP) |
D00525 |
CYP2A6 |
|
|
Pilocarpine borate |
D08376 |
CYP2A6 |
|
|
Pilocarpine hydrochloride (JP18/USP) |
D02200 |
CYP2A6 |
|
|
Pilocarpine nitrate (USP) |
D05478 |
CYP2A6 |
|
|
Pimavanserin tartrate (USAN) |
D08969 |
CYP3A4, CYP3A5; CYP2J2, CYP2D6 |
|
|
Pimitespib (JAN) |
D11920 |
|
CYP3A |
|
Pimozide (JP18/USP/INN) |
D00560 |
CYP3A4; CYP2D6 |
|
|
Pindolol (JP18/USP/INN) |
D00513 |
CYP2D6 |
|
|
Pioglitazone (INN) |
D08378 |
CYP2C8 |
|
|
Pioglitazone hydrochloride (JP18/USP) |
D00945 |
CYP2C8 |
|
|
Pioglitazone hydrochloride and glimepiride tablets (JP18) |
D09848 |
CYP2C8, CYP2C9 |
|
|
Pipemidic acid (INN) |
D08379 |
|
CYP1A2 |
|
Pipemidic acid hydrate (JP18) |
D01531 |
|
CYP1A2 |
|
Pirfenidone (JAN/USAN/INN) |
D01583 |
CYP1A2; CYP2C9, CYP2C19, CYP2D6, CYP2E1 |
|
|
Piroxicam (JP18/USP/INN) |
D00127 |
CYP2C9 |
|
|
Piroxicam betadex (USAN) |
D05511 |
CYP2C9 |
|
|
Piroxicam cinnamate (USAN) |
D05512 |
CYP2C9 |
|
|
Piroxicam olamine (USAN) |
D05513 |
CYP2C9 |
|
|
Pirtobrutinib (JAN/USAN) |
D12050 |
CYP3A4 |
CYP2C8, CYP2C19, CYP3A |
|
Pitavastatin calcium (JAN) |
D01862 |
CYP2C9 |
|
|
Pitavastatin calcium hydrate (JP18) |
D10568 |
CYP2C9 |
|
|
Pitavastatin magnesium |
D11092 |
CYP2C9 |
|
|
Pitolisant (USAN/INN) |
D10749 |
CYP2D6; CYP3A4 |
|
|
Pitolisant hydrochloride (USAN) |
D11490 |
CYP2D6; CYP3A4 |
|
|
Platycodon fluidextract, glycyrrhiza extract, plantago herb extract, peony root extract and dihydrocodeine phosphate |
D08697 |
UGT2B7, UGT2B4; CYP3A4, CYP2D6 |
|
|
Polatuzumab vedotin (USAN) |
D10761 |
CYP3A |
|
|
Pomalidomide (JAN/USAN/INN) |
D08976 |
CYP1A2, CYP3A4 |
|
|
Ponatinib (USAN/INN) |
D09950 |
CYP3A |
|
|
Ponatinib hydrochloride (JAN/USAN) |
D09951 |
CYP3A |
|
|
Posaconazole (JAN/USAN/INN) |
D02555 |
|
CYP3A4 |
|
Pranlukast (INN) |
D08408 |
CYP3A4 |
|
|
Pranlukast hydrate (JP18) |
D02732 |
CYP3A4 |
|
|
Praziquantel (JAN/USP/INN) |
D00471 |
CYP3A4 |
|
|
Prednisolone (JP18/USP/INN) |
D00472 |
CYP3A |
|
|
Procainamide (INN) |
D08421 |
NAT |
|
|
Procainamide hydrochloride (JP18/USP) |
D00477 |
NAT |
|
|
Procaterol (INN) |
D08424 |
CYP3A4 |
|
|
Procaterol hydrochloride (USAN) |
D02404 |
CYP3A4 |
|
|
Procaterol hydrochloride hydrate (JP18) |
D05366 |
CYP3A4 |
|
|
Progesterone (JP18/USP/INN) |
D00066 |
CYP3A4, CYP2C19 |
|
|
Proguanil (INN) |
D08428 |
CYP2C19 |
|
|
Proguanil hydrochloride (JAN/USP) |
D02487 |
CYP2C19 |
|
|
Promethazine (JAN/INN) |
D00494 |
CYP2D6 |
|
|
Promethazine hibenzate |
D08768 |
CYP2D6 |
|
|
Promethazine hydrochloride (JP18/USP) |
D00480 |
CYP2D6 |
|
|
Promethazine maleate |
D08432 |
CYP2D6 |
|
|
Promethazine methylenedisalicylate (JAN) |
D03290 |
CYP2D6 |
|
|
Promethazine teoclate (JAN/INN) |
D01242 |
CYP2D6 |
|
|
Propafenone (INN) |
D08435 |
CYP2D6, CYP3A4, CYP1A2 |
|
|
Propafenone hydrochloride (JP18/USP) |
D00640 |
CYP2D6, CYP3A4, CYP1A2 |
|
|
Propiverine (INN) |
D08441 |
CYP3A4 |
|
|
Propiverine hydrochloride (JP18) |
D01007 |
CYP3A4 |
|
|
Propranolol (INN) |
D08443 |
CYP2D6, CYP1A2, CYP2C19 |
|
|
Propranolol hydrochloride (JP18/USP) |
D00483 |
CYP2D6, CYP1A2, CYP2C19 |
|
|
Proxyphylline, ephedrine hydrochloride and phenobarbital |
D04307 |
|
|
CYP3A |
Quazepam (JAN/USP/INN) |
D00457 |
CYP2C9, CYP3A4 |
|
|
Quetiapine (INN) |
D08456 |
CYP3A4 |
|
|
Quetiapine fumarate (JP18/USP) |
D00458 |
CYP3A4 |
|
|
Quinine (BAN) |
D08460 |
CYP3A4 |
|
|
Quinine ascorbate (USAN) |
D05681 |
CYP3A4 |
|
|
Quinine dihydrochloride |
D08461 |
CYP3A4 |
|
|
Quinine ethylcarbonate (JP18) |
D01663 |
CYP3A4 |
|
|
Quinine hydrochloride hydrate (JP18) |
D02261 |
CYP3A4 |
|
|
Quinine sulfate (USP) |
D02262 |
CYP3A4 |
|
|
Quinupristin and dalfopristin |
D00854 |
|
CYP3A4 |
|
Quizartinib (USAN/INN) |
D09955 |
CYP3A |
|
|
Quizartinib dihydrochloride (USAN) |
D09956 |
CYP3A |
|
|
Rabeprazole (INN) |
D08463 |
CYP2C19, CYP3A4 |
|
|
Rabeprazole sodium (JP18/USP) |
D00724 |
CYP2C19, CYP3A4 |
|
|
Rabeprazole, amoxicillin and clarithromycin |
D10519 |
CYP2C19, CYP3A4 |
CYP3A4 |
|
Rabeprazole, amoxicillin and metronidazole |
D10520 |
CYP2C19, CYP3A4 |
|
|
Raltegravir (INN) |
D06676 |
UGT1A1 |
|
|
Raltegravir potassium (JAN/USAN) |
D07133 |
UGT1A1 |
|
|
Ramelteon (JAN/USAN/INN) |
D02689 |
CYP1A2 |
|
|
Ramosetron (INN) |
D08466 |
CYP1A2, CYP2D6 |
|
|
Ramosetron hydrochloride (JAN) |
D02016 |
CYP1A2, CYP2D6 |
|
|
Ranitidine (USAN/INN) |
D00422 |
|
CYP2D6, CYP3A |
|
Ranitidine bismuth citrate (USAN) |
D05699 |
|
CYP2D6, CYP3A |
|
Ranitidine hydrochloride (JP18/USP) |
D00673 |
|
CYP2D6, CYP3A |
|
Ranolazine (USAN/INN) |
D05700 |
CYP3A |
CYP2D6 |
|
Ranolazine hydrochloride (USAN) |
D05701 |
CYP3A |
CYP2D6 |
|
Rasagiline (USAN/INN) |
D08469 |
CYP1A2 |
|
|
Rasagiline mesylate (USAN) |
D02562 |
CYP1A2 |
|
|
Rasagiline tartrate |
D10829 |
CYP1A2 |
|
|
Ravuconazole (prop.INN) |
D02556 |
|
CYP3A |
|
Rebamipide (JP18/INN) |
D01121 |
CYP3A4 |
|
|
Regorafenib (USAN/INN) |
D10138 |
CYP3A4, UGT1A9 |
|
|
Regorafenib hydrate (JAN) |
D10137 |
CYP3A4, UGT1A9 |
|
|
Repaglinide (JAN/USP/INN) |
D00594 |
CYP2C8; CYP3A4 |
|
|
Repotrectinib (JAN/USAN) |
D11454 |
CYP3A4 |
|
|
Retinol acetate (JP18) |
D01621 |
CYP2C8 |
|
|
Retinol palmitate (JP18) |
D00164 |
CYP2C8 |
|
|
Retinol propionate |
D08477 |
CYP2C8 |
|
|
Ribociclib (USAN/INN) |
D10883 |
CYP3A4 |
|
|
Ribociclib succinate (USAN) |
D10979 |
CYP3A4 |
|
|
Rifabutin (JAN/USP/INN) |
D00424 |
CYP3A4 |
|
CYP3A |
Rifampicin sodium |
D08479 |
|
|
CYP3A4, UGT |
Rifampin (USP) |
D00211 |
|
|
CYP3A4, UGT |
Rifapentine (USAN/INN) |
D00879 |
|
|
CYP3A4, CYP2C8, CYP2C9 |
Rifaximin (JAN/USAN/INN) |
D02554 |
CYP3A4 |
|
CYP3A4 |
Rilmazafone (INN) |
D08481 |
CES, CYP3A4 |
|
|
Rilmazafone hydrochloride hydrate (JP18) |
D01564 |
CES, CYP3A4 |
|
|
Rilpivirine (JAN/USAN/INN) |
D09720 |
CYP3A |
|
|
Rilpivirine hydrochloride (JAN/USAN) |
D09958 |
CYP3A |
|
|
Rilpivirine hydrochloride, tenofovir disoproxil fumarate and emtricitabine |
D10571 |
CYP3A |
|
|
Riluzole (JAN/USP/INN) |
D00775 |
CYP1A2 |
|
|
Rimegepant (USAN/INN) |
D10662 |
CYP3A4; CYP2C9 |
|
|
Rimegepant sulfate (USAN) |
D10663 |
CYP3A4; CYP2C9 |
|
|
Riociguat (JAN/USAN/INN) |
D09572 |
CYP1A1, CYP2C8, CYP2J2, CYP3A |
|
|
Risdiplam (JAN/USAN/INN) |
D11406 |
FMO1, FMO3, CYP1A1, CYP2J2, CYP3A4, CYP3A7 |
|
|
Risperidone (JP18/USP/INN) |
D00426 |
CYP2D6, CYP3A4 |
|
|
Ritlecitinib tosylate (USAN) |
D11970 |
|
CYP3A, CYP1A2 |
|
Ritonavir (JAN/USP/INN) |
D00427 |
CYP3A, CYP2D6 |
CYP3A |
CYP1A2, CYP2C9, CYP2C19 |
Rivaroxaban (JAN/USAN/INN) |
D07086 |
CYP3A4, CYP2J2 |
|
|
Roflumilast (JAN/USAN/INN) |
D05744 |
CYP3A4, CYP1A2 |
|
|
Rolapitant (USAN/INN) |
D10742 |
CYP3A4 |
CYP2D6 |
|
Rolapitant hydrochloride (USAN) |
D08988 |
CYP3A4 |
CYP2D6 |
|
Romidepsin (JAN/USAN/INN) |
D06637 |
CYP3A |
|
|
Ropinirole (USAN/INN) |
D08489 |
CYP1A2 |
|
|
Ropinirole hydrochloride (JAN/USP) |
D00784 |
CYP1A2 |
|
|
Ropivacaine (INN) |
D08490 |
CYP1A2, CYP3A4 |
|
|
Ropivacaine hydrochloride (USP) |
D04048 |
CYP1A2, CYP3A4 |
|
|
Roxadustat (JAN/USAN/INN) |
D10593 |
CYP2C8, UGT1A9 |
|
|
Roxithromycin (JP18/USAN/INN) |
D01710 |
CYP3A |
|
|
Rufinamide (JAN/USP/INN) |
D05775 |
CES |
|
|
Rupatadine (INN) |
D07407 |
CYP3A4 |
|
|
Rupatadine fumarate (JAN) |
D08497 |
CYP3A4 |
|
|
Ruxolitinib (USAN/INN) |
D09959 |
CYP3A4; CYP2C9 |
|
|
Ruxolitinib phosphate (JAN/USAN) |
D09960 |
CYP3A4; CYP2C9 |
|
|
Sacituzumab govitecan (USAN/INN) |
D10985 |
UGT1A1 |
|
|
Safinamide (USAN/INN) |
D10158 |
MAOA; CYP3A4 |
|
|
Safinamide mesylate (USAN) |
D10191 |
MAOA; CYP3A4 |
|
|
Salmeterol (USAN/INN) |
D05792 |
CYP3A4 |
|
|
Salmeterol xinafoate (JAN/USP) |
D00687 |
CYP3A4 |
|
|
Salmeterol xinafoate and fluticasone propionate |
D08699 |
CYP3A4 |
|
|
Saquinavir (JAN/USP/INN) |
D00429 |
CYP3A4 |
|
|
Saquinavir mesylate (USP) |
D01160 |
CYP3A4 |
|
|
Sarpogrelate (INN) |
D08508 |
CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP3A4 |
|
|
Sarpogrelate hydrochloride (JP18) |
D01624 |
CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP3A4 |
|
|
Saxagliptin (USAN/INN) |
D08996 |
CYP3A4, CYP3A5 |
|
|
Saxagliptin hydrate (JAN) |
D09753 |
CYP3A4, CYP3A5 |
|
|
Saxagliptin hydrochloride |
D10262 |
CYP3A4, CYP3A5 |
|
|
Selegiline (USAN/INN) |
D03731 |
CYP2B6, CYP2D6, CYP3A4; CYP2A6 |
|
|
Selegiline hydrochloride (JAN/USP) |
D00785 |
CYP2B6, CYP2D6, CYP3A4; CYP2A6 |
|
|
Selexipag (JAN/USAN/INN) |
D09994 |
CYP2C8, CYP3A4, UGT1A3, UGT2B7 |
|
|
Selinexor (USAN/INN) |
D11222 |
CYP3A4, UGT, GST |
|
|
Selpercatinib (JAN/USAN/INN) |
D11713 |
CYP3A4 |
|
|
Selumetinib (USAN/INN) |
D09666 |
CYP3A4, UGT1A1, UGT1A3; CYP2C19, CYP1A2, CYP2C9, CYP2E1, CYP3A5 |
|
|
Selumetinib sulfate (JAN/USAN) |
D10024 |
CYP3A4, UGT1A1, UGT1A3; CYP2C19, CYP1A2, CYP2C9, CYP2E1, CYP3A5 |
|
|
Sertraline (INN) |
D02360 |
CYP2C19, CYP2C9, CYP2B6, CYP3A4 |
|
|
Sertraline hydrochloride (JAN/USP) |
D00825 |
CYP2C19, CYP2C9, CYP2B6, CYP3A4 |
|
|
Sildenafil (INN) |
D08514 |
CYP3A4; CYP2C9 |
|
|
Sildenafil citrate (JAN/USP) |
D02229 |
CYP3A4; CYP2C9 |
|
|
Silodosin (JP18/INN) |
D01965 |
CYP3A4, UGT |
|
|
Simeprevir (JAN/USAN) |
D10081 |
CYP3A |
CYP3A |
|
Simeprevir sodium (JAN) |
D10469 |
CYP3A |
CYP3A |
|
Simvastatin (JP18/USP/INN) |
D00434 |
CYP3A4 |
|
|
Siponimod (USAN/INN) |
D11460 |
CYP2C9; CYP3A4 |
|
|
Siponimod fumarate (USAN) |
D11072 |
CYP2C9; CYP3A4 |
|
|
Sirolimus (JAN/USAN/INN) |
D00753 |
CYP3A4 |
CYP3A4 |
|
Sitagliptin and ipragliflozin |
D11064 |
UGT2B7 |
|
|
Sodium aceneuramate (JAN) |
D09855 |
NPL |
|
|
Sofosbuvir and velpatasvir |
D10827 |
CYP2B6, CYP2C8, CYP3A4 |
|
|
Sofpironium bromide (JAN/USAN/INN) |
D10989 |
CYP2D6, CYP3A4 |
|
|
Solifenacin (INN) |
D08522 |
CYP3A4 |
|
|
Solifenacin succinate (JAN/USAN/INN) |
D01269 |
CYP3A4 |
|
|
Somatropin (USP/INN) |
D02691 |
|
CYP2C19 |
|
Sonidegib (USAN/INN) |
D10119 |
CYP3A |
|
|
Sonidegib phosphate (USAN) |
D10729 |
CYP3A |
|
|
Sotagliflozin (USAN/INN) |
D10669 |
UGT1A9; CYP3A4 |
|
|
Sotorasib (JAN/USAN) |
D12055 |
CYP3A |
|
|
Sparsentan (USAN/INN) |
D11776 |
CYP3A |
|
|
Sparteine (INN) |
D01041 |
CYP2D6 |
|
|
Sparteine sulfate (JAN/USAN) |
D02239 |
CYP2D6 |
|
|
Stiripentol (JAN/USAN/INN) |
D05928 |
CYP1A2, CYP2C19, CYP3A4 |
CYP1A2, CYP3A4, CYP2D6, CYP2C19, CYP2C9 |
|
Sumatriptan (JAN/USP/INN) |
D00451 |
MAOA |
|
|
Sumatriptan succinate (JAN/USP) |
D00676 |
MAOA |
|
|
Sunitinib (INN) |
D08552 |
CYP3A4 |
|
|
Sunitinib malate (JAN/USAN) |
D06402 |
CYP3A4 |
|
|
Suprofen (JAN/USP/INN) |
D00452 |
CYP2C9 |
|
|
Suvorexant (JAN/USAN) |
D10082 |
CYP3A; CYP2C19 |
|
|
Synthetic conjugated estrogens, B (USAN) |
D05987 |
CYP3A4 |
|
|
Tacrine (INN) |
D08555 |
CYP1A2 |
|
|
Tacrine hydrochloride (USP) |
D02068 |
CYP1A2 |
|
|
Tacrolimus (INN) |
D08556 |
CYP3A4 |
|
|
Tacrolimus (USP/INN) |
D00107 |
CYP3A4 |
|
|
Tadalafil (JAN/USP/INN) |
D02008 |
CYP3A4 |
|
|
Tamibarotene (JAN/USAN/INN) |
D01418 |
CYP3A4 |
|
|
Tamoxifen (INN) |
D08559 |
CYP2D6, CYP3A4 |
|
|
Tamoxifen citrate (JP18/USP) |
D00966 |
CYP2D6, CYP3A4 |
|
|
Tapentadol (USAN/INN) |
D06007 |
UGT |
|
|
Tapentadol hydrochloride (JAN) |
D10199 |
UGT |
|
|
Tasimelteon (USAN/INN) |
D09388 |
CYP3A4, CYP1A2 |
|
|
Tecovirimat (USAN/INN) |
D09390 |
UGT1A1, UGT1A4 |
|
|
Tecovirimat hydrate (JAN) |
D11557 |
UGT1A1, UGT1A4 |
|
|
Tegafur (JP18/USAN/INN) |
D01244 |
CYP2A6 |
|
|
Tegaserod (USAN/INN) |
D06056 |
UGT |
|
|
Tegaserod maleate (USAN) |
D02730 |
UGT |
|
|
Telaprevir (JAN/USAN/INN) |
D09012 |
CYP3A4 |
CYP3A4, CYP3A5 |
|
Telithromycin (JAN/USAN/INN) |
D01078 |
CYP3A, CYP2D6 |
CYP3A, CYP2D6 |
|
Telmisartan (JP18/USP/INN) |
D00627 |
UGT |
|
|
Telmisartan and amlodipine besilate (JP18) |
D09743 |
CYP3A4, UGT |
|
|
Telmisartan and hydrochlorothiazide (JP18) |
D09219 |
UGT |
|
|
Telmisartan, amlodipine and hydrochlorothiazide |
D10805 |
CYP3A4, UGT |
|
|
Temsavir (USAN/INN) |
D10734 |
CYP3A |
|
|
Temsirolimus (JAN/USAN/INN) |
D06068 |
CYP3A4 |
|
|
Tenapanor (USAN/INN) |
D11652 |
CYP3A4, CYP3A5 |
|
|
Tenapanor hydrochloride (JAN/USAN) |
D11653 |
CYP3A4, CYP3A5 |
|
|
Teneligliptin (INN) |
D08616 |
CYP3A4, FMO1, FMO3 |
CYP2D6, CYP3A4, FMO |
|
Teneligliptin and canagliflozin |
D10897 |
CYP3A4, FMO1, FMO3, UGT1A9, UGT2B4 |
|
|
Teneligliptin hydrobromide (JAN) |
D11968 |
CYP3A4, FMO1, FMO3 |
CYP2D6, CYP3A4, FMO |
|
Teneligliptin hydrobromide hydrate (JAN) |
D09756 |
CYP3A4, FMO1, FMO3 |
CYP2D6, CYP3A4, FMO |
|
Tenoxicam (JAN/USAN/INN) |
D01767 |
CYP2C9 |
|
|
Tepotinib (USAN/INN) |
D11717 |
CYP3A4, CYP2C8 |
|
|
Tepotinib hydrochloride (USAN) |
D11073 |
CYP3A4, CYP2C8 |
|
|
Terbinafine (USAN/INN) |
D02375 |
CYP2C9, CYP1A2, CYP3A4, CYP2C8, CYP2C19 |
CYP2D6 |
|
Terbinafine hydrochloride (JP18/USP) |
D02219 |
CYP2C9, CYP1A2, CYP3A4, CYP2C8, CYP2C19 |
CYP2D6 |
|
Terfenadine (JAN/USAN/INN) |
D00521 |
CYP3A |
|
|
Tetrabenazine (JAN/INN) |
D08575 |
CYP2D6; CYP3A4, CYP1A2, CBR |
|
|
Theophylline (JP18) |
D00371 |
CYP1A2 |
|
|
Theophylline (USP) |
D06103 |
CYP1A2 |
|
|
Theophylline sodium acetate (JAN) |
D01712 |
CYP1A2 |
|
|
Theophylline sodium glycinate (USP) |
D06104 |
CYP1A2 |
|
|
Ticagrelor (JAN/USAN/INN) |
D09017 |
CYP3A |
CYP3A |
|
Ticlopidine (INN) |
D08594 |
|
CYP2C19, CYP1A2, CYP2B6, CYP2D6 |
|
Ticlopidine hydrochloride (JP18/USP) |
D01028 |
|
CYP2C19, CYP1A2, CYP2B6, CYP2D6 |
|
Timolol (INN) |
D08600 |
CYP2D6 |
|
|
Timolol (USAN) |
D00378 |
CYP2D6 |
|
|
Timolol maleate (JP18/USP) |
D00603 |
CYP2D6 |
|
|
Tiotropium and olodaterol |
D10744 |
UGT |
|
|
Tivozanib (USAN/INN) |
D09683 |
CYP3A4 |
|
|
Tivozanib hydrochloride (USAN) |
D10190 |
CYP3A4 |
|
|
Tizanidine (INN) |
D08611 |
CYP1A2 |
|
|
Tizanidine hydrochloride (JP18/USP) |
D00776 |
CYP1A2 |
|
|
Tofacitinib (USAN) |
D09970 |
CYP3A4; CYP2C19 |
|
|
Tofacitinib citrate (JAN/USAN) |
D09783 |
CYP3A4; CYP2C19 |
|
|
Tofogliflozin (USAN) |
D09978 |
CYP2C18, CYP4A11, CYP4F3 |
|
|
Tolcapone (JAN/USP/INN) |
D00786 |
|
COMT |
|
Tolterodine (USAN/INN) |
D00646 |
CYP2D6, CYP3A4 |
|
|
Tolterodine tartrate (JAN/USP) |
D01148 |
CYP2D6, CYP3A4 |
|
|
Tolvaptan (JP18/USAN/INN) |
D01213 |
CYP3A4 |
|
|
Topiramate (JAN/USP/INN) |
D00537 |
CYP3A4 |
|
|
Torasemide sodium |
D08619 |
CYP2C9, CYP2C8 |
|
|
Toremifene (INN) |
D08620 |
CYP3A4 |
|
|
Toremifene citrate (JAN/USAN) |
D00967 |
CYP3A4 |
|
|
Torsemide (USP) |
D00382 |
CYP2C9, CYP2C8 |
|
|
Trabectedin (JAN/USAN/INN) |
D06199 |
CYP3A4 |
|
|
Tramadol (INN) |
D08623 |
CYP2D6, CYP3A4 |
|
|
Tramadol hydrochloride (JP18/USP) |
D01355 |
CYP2D6, CYP3A4 |
|
|
Tramadol hydrochloride and acetaminophen |
D09999 |
CYP2D6, CYP3A4 |
|
|
Tranilast (JP18/USAN/INN) |
D02027 |
CYP2C9 |
|
|
Trazodone (INN) |
D08626 |
CYP3A4, CYP2D6 |
|
|
Trazodone hydrochloride (JAN/USP) |
D00820 |
CYP3A4, CYP2D6 |
|
|
Trelagliptin (USAN) |
D10178 |
CYP2D6 |
|
|
Trelagliptin succinate (JAN/USAN) |
D10179 |
CYP2D6 |
|
|
Treprostinil (JAN/USAN/INN) |
D06213 |
CYP2C8 |
|
|
Treprostinil diolamine (USAN) |
D10430 |
CYP2C8 |
|
|
Treprostinil monosodium salt |
D08628 |
CYP2C8 |
|
|
Treprostinil palmitil (USAN/INN) |
D12005 |
CYP2C8 |
|
|
Treprostinil phosphate (USAN) |
D12629 |
CYP2C8 |
|
|
Triazolam (JP18/USP/INN) |
D00387 |
CYP3A4 |
|
|
Trimethoprim (JAN/USP/INN) |
D00145 |
|
CYP2C8 |
|
Trimethoprim hydrochloride |
D11085 |
|
CYP2C8 |
|
Trimethoprim lactate |
D08644 |
|
CYP2C8 |
|
Trimethoprim sulfate (USP) |
D06236 |
|
CYP2C8 |
|
Tripelennamine (INN) |
D08645 |
|
CYP2D6 |
|
Tripelennamine citrate |
D06246 |
|
CYP2D6 |
|
Tripelennamine hydrochloride (USP) |
D02091 |
|
CYP2D6 |
|
Troglitazone (JAN/USAN/INN) |
D00395 |
|
|
CYP3A |
Troleandomycin (USAN/INN) |
D01322 |
CYP3A4 |
CYP3A4 |
|
Tucatinib (USAN/INN) |
D11141 |
CYP2C8; CYP3A |
|
|
Tucatinib ethanolate (JAN) |
D12442 |
CYP2C8; CYP3A |
|
|
Ubrogepant (USAN/INN) |
D10673 |
CYP3A4 |
|
|
Umeclidinium (USAN) |
D10180 |
CYP2D6 |
|
|
Umeclidinium bromide (JAN/USAN) |
D10181 |
CYP2D6 |
|
|
Umeclidinium bromide and vilanterol |
D10533 |
CYP2D6, CYP3A4 |
|
|
Upadacitinib (USAN/INN) |
D10994 |
CYP3A4; CYP2D6 |
|
|
Upadacitinib hydrate (JAN) |
D11048 |
CYP3A4; CYP2D6 |
|
|
Upadacitinib tartrate (USAN) |
D10995 |
CYP3A4; CYP2D6 |
|
|
Urapidil (JP18/INN) |
D01333 |
CYP2D6 |
|
|
Urapidil hydrochloride |
D08662 |
CYP2D6 |
|
|
Valbenazine (USAN/INN) |
D10675 |
CYP3A4, CYP3A5; CYP2D6 |
|
|
Valbenazine tosylate (USAN) |
D10999 |
CYP3A4, CYP3A5; CYP2D6 |
|
|
Valsartan (JP18/USP/INN) |
D00400 |
CYP2C9 |
|
|
Valsartan and amlodipine besilate |
D09745 |
CYP3A4 |
|
|
Valsartan and cilnidipine |
D10525 |
CYP3A4; CYP2C19 |
|
|
Vamorolone (USAN/INN) |
D11000 |
CYP3A4, CYP3A5, CYP2C8, UGT1A3, UGT2B7, UGT2B17 |
|
|
Vandetanib (JAN/USAN/INN) |
D06407 |
CYP3A4 |
|
|
Vaniprevir (JAN/USAN/INN) |
D09987 |
CYP3A |
|
|
Vardenafil (USAN/INN) |
D08668 |
CYP3A4 |
|
|
Vardenafil dihydrochoride (USAN) |
D02731 |
CYP3A4 |
|
|
Vardenafil hydrochloride (USP) |
D09989 |
CYP3A4 |
|
|
Vardenafil hydrochloride hydrate (JAN) |
D03260 |
CYP3A4 |
|
|
Vemurafenib (JAN/USAN/INN) |
D09996 |
|
CYP1A2, CYP2C9 |
CYP3A4 |
Venlafaxine (INN) |
D08670 |
CYP2D6; CYP3A4 |
|
|
Venlafaxine besylate monohydrate |
D12403 |
CYP2D6; CYP3A4 |
|
|
Venlafaxine hydrochloride (JAN/USP) |
D00821 |
CYP2D6; CYP3A4 |
|
|
Verapamil (USAN/INN) |
D02356 |
CYP3A4 |
CYP3A4 |
|
Verapamil hydrochloride (JP18/USP) |
D00619 |
CYP3A4 |
CYP3A4 |
|
Vericiguat (JAN/USAN/INN) |
D11051 |
UGT1A9; UGT1A1 |
|
|
Vibegron (JAN/USAN/INN) |
D10433 |
CYP3A4 |
|
|
Vilazodone (USAN/INN) |
D09698 |
CYP3A4; CYP2D6, CYP2C19 |
|
|
Vilazodone hydrochloride (USAN) |
D09699 |
CYP3A4; CYP2D6, CYP2C19 |
|
|
Viloxazine (INN) |
D08673 |
CYP2D6, UGT1A9, UGT2B15 |
|
|
Viloxazine hydrochloride (USAN) |
D02572 |
CYP2D6, UGT1A9, UGT2B15 |
|
|
Vinblastine (INN) |
D08675 |
CYP3A4 |
|
|
Vinblastine sulfate (JP18/USP) |
D01068 |
CYP3A4 |
|
|
Vincristine (INN) |
D08679 |
CYP3A |
|
|
Vincristine sulfate (JP18/USP) |
D02197 |
CYP3A |
|
|
Vindesine (USAN/INN) |
D06304 |
CYP3A |
|
|
Vindesine sulfate (JAN/USAN) |
D01769 |
CYP3A |
|
|
Vinorelbine (INN) |
D08680 |
CYP3A4 |
|
|
Vinorelbine tartrate (USP) |
D01935 |
CYP3A4 |
|
|
Vitamin A (USP) |
D06543 |
CYP2C8 |
|
|
Vitamin A oil (JP18) |
D00069 |
CYP2C8 |
|
|
Voclosporin (JAN/USAN/INN) |
D09033 |
CYP3A4 |
|
|
Vonoprazan (USAN/INN) |
D11784 |
CYP3A4; CYP2B6, CYP2C19, CYP2D6 |
|
|
Vonoprazan and amoxicillin |
D12756 |
CYP3A4, CYP3A5, CYP2B6, CYP2C19, CYP2C9, CYP2D6 |
|
|
Vonoprazan fumarate (JAN/USAN) |
D10466 |
CYP3A4; CYP2B6, CYP2C19, CYP2D6 |
|
|
Vonoprazan, amoxicillin and clarithromycin |
D10775 |
CYP3A4; CYP2B6, CYP2C19, CYP2D6 |
CYP3A4 |
|
Vonoprazan, amoxicillin and metronidazole |
D10774 |
CYP3A4; CYP2B6, CYP2C19, CYP2D6 |
|
|
Vorapaxar (USAN/INN) |
D09765 |
CYP3A4, CYP2J2 |
|
|
Vorapaxar sulfate (JAN/USAN) |
D09766 |
CYP3A4, CYP2J2 |
|
|
Vorasidenib (USAN/INN) |
D11834 |
CYP1A2; CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP3A |
|
|
Vorasidenib citrate (USAN) |
D11835 |
CYP1A2; CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP3A |
|
|
Voriconazole (JP18/USP/INN) |
D00578 |
|
CYP3A |
|
Vorinostat (JAN/USAN) |
D06320 |
UGT |
|
|
Vortioxetine (USAN) |
D10184 |
CYP2D6; CYP3A4, CYP3A5, CYP2C19, CYP2C9, CYP2A6, CYP2C8, CYP2B6 |
|
|
Vortioxetine hemihydrobromide (USAN) |
D12544 |
CYP2D6; CYP3A4, CYP3A5, CYP2C19, CYP2C9, CYP2A6, CYP2C8, CYP2B6 |
|
|
Vortioxetine hydrobromide (JAN/USAN) |
D10185 |
CYP2D6; CYP3A4, CYP3A5, CYP2C19, CYP2C9, CYP2A6, CYP2C8, CYP2B6 |
|
|
Voxelotor (USAN) |
D11330 |
CYP3A4; CYP2C19, CYP2B6, CYP2C9 |
|
|
Warfarin (INN) |
D08682 |
CYP2C9 |
|
|
Warfarin potassium (JP18) |
D01280 |
CYP2C9 |
|
|
Warfarin sodium (USP) |
D00564 |
CYP2C9 |
|
|
Xanomeline and trospium chloride |
D12968 |
CYP2D6 |
|
|
Zaleplon (JAN/USP/INN) |
D00530 |
AOX1, CYP3A4 |
|
|
Zanubrutinib (JAN/USAN/INN) |
D11422 |
CYP3A |
|
|
Zilucoplan (USAN/INN) |
D12357 |
CYP4F2 |
|
|
Zilucoplan sodium (JAN) |
D12356 |
CYP4F2 |
|
|
Zolmitriptan (JAN/USP/INN) |
D00415 |
CYP1A2, MAOA |
|
|
Zolpidem (INN) |
D08690 |
CYP3A4; CYP2C9, CYP1A2 |
|
|
Zolpidem tartrate (JP18/USP) |
D00706 |
CYP3A4; CYP2C9, CYP1A2 |
|
|
Zonisamide (JP18/USP/INN) |
D00538 |
CYP3A |
|
|
Zopiclone (JP18/INN) |
D01372 |
CYP3A4; CYP2C8 |
|
|
Zuclopenthixol (INN) |
D03556 |
CYP2D6 |
|
|
Zuclopenthixol acetate |
D08691 |
CYP2D6 |
|
|
Zuclopenthixol decanoate |
D08692 |
CYP2D6 |
|
|
Zuclopenthixol dihydrochloride |
D08693 |
CYP2D6 |
|
|
Zuranolone (JAN/USAN/INN) |
D11793 |
CYP3A4 |
|
|
dl-Methylephedrine hydrochloride, dihydrocodeine phosphate, diprophylline, diphenhydramine salicylate, acetaminophen and bromovalerylurea |
D08695 |
UGT2B7, UGT2B4; CYP3A4, CYP2D6 |
|
|
l-Isoprenaline hydrochloride (JP18) |
D02150 |
COMT |
|
|